Curable resin composition, method for producing curable resin composition, cured film, laminated body, method for producing cured film, and semiconductor device
By introducing specific compounds into the curable resin composition to promote the cyclization of polymer precursors, the problem of insufficient film strength in the prior art is solved, and a high-strength and stable cured film is achieved.
Patent Information
- Application Number
- CN202080045920.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2019-07-01
- Filing Date
- 2020-07-01
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2040-07-01
AI Technical Summary
In the prior art, curable resin compositions containing heterocyclic polymer precursors exhibit insufficient film strength during the curing process, making it difficult to meet the requirements of certain applications.
A curable resin composition comprising a polyimide precursor or a polybenzoxazole precursor, a basic compound with a specific structure or its weak acid salt, a polymerization initiator, and a solvent is used to promote the cyclization of the polymer precursor through a specific compound, thereby increasing the ring-closure rate and enhancing the film strength.
Through the action of specific compounds, the film strength and chemical resistance of the cured film are significantly improved, while maintaining good storage stability and adaptability.
Smart Images

Figure CN114008526B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to a curable resin composition, a method for producing the curable resin composition, a cured film, a laminate, a method for producing a cured film, and a semiconductor device. Background Art
[0002] The resin cured by cyclizing the precursor of a polymer such as a polyimide resin or a polybenzoxazole resin (hereinafter, the precursor of the polyimide resin and the precursor of the polybenzoxazole resin are also collectively referred to as "polymer precursors containing heterocyclic rings"). It is suitable for various uses due to its excellent heat resistance and insulation properties. The above-mentioned uses are not particularly limited. If a semiconductor device for actual installation is taken as an example, the use as a material or protective film for an insulating film or a sealant can be cited. In addition, it is also used as a base film or a cover film of a flexible substrate.
[0003] For example, in the above-mentioned use, a polymer precursor containing a heterocycle is used in the form of a curable resin composition containing a polymer precursor containing a heterocycle. Such a curable resin composition is applied to a substrate, for example, by coating, and then, the above-mentioned polymer precursor containing a heterocycle is cyclized by heating, so that a cured resin can be formed on the substrate. Since the curable resin composition can be applied by a known coating method, it can be said that the adaptability in manufacturing is excellent, for example, the shape, size, application position, etc. of the curable resin composition to be applied are high in design freedom.
[0004] In addition to the high performance of polyimide and the like, the industrial application development of curable resin compositions containing polymer precursors containing heterocyclic rings is increasingly expected from the viewpoint of excellent adaptability in production.
[0005] For example, Patent Document 1 describes a polyimide precursor composition comprising a polyamic acid having repeating units of a specific structure and a basic compound selected from the group consisting of imidazoles and amine compounds dissolved in a mixed solvent consisting of water and N-methyl-2-pyrrolidone with a water ratio of 10 to 90% by mass.
[0006] Patent document 2 describes a polyimide resin composition for electrodeposition, which is characterized in that it contains: a solvent-soluble polyimide, which is a solvent-soluble polyimide of a specific structure, and 3 to 100% of the total molar number of diamines or triamines in the specific structure have sulfonic acid groups and / or sulfinic acid groups introduced into the skeleton; water; and a basic compound.
[0007] Previous technical literature
[0008] Patent Literature
[0009] Patent Document 1: Japanese Patent Application Publication No. 2016-017145
[0010] Patent Document 2: Japanese Patent Application Publication No. 2008-291265 Summary of the invention
[0011] Technical issues to be solved by the invention
[0012] It is desired to provide a curable resin composition including a polymer precursor containing a heterocyclic ring, in which the obtained cured product has excellent film strength.
[0013] An object of the present invention is to provide a curable resin composition having excellent film strength of the obtained cured film, a method for producing the above-mentioned curable resin composition, a cured film formed by curing the above-mentioned curable resin composition, a laminate comprising the above-mentioned cured film, a method for producing the above-mentioned cured film, and a semiconductor device comprising the above-mentioned cured film or the above-mentioned laminate.
[0014] Means for solving technical problems
[0015] Representative embodiments of the present invention are shown below.
[0016] <1> A curable resin composition comprising: at least one resin selected from the group consisting of a polyimide precursor and a polybenzoxazole precursor;
[0017] A basic compound represented by the following formula (1-1) or a weak acid salt thereof;
[0018] a polymerization initiator; and
[0019] Solvent.
[0020] [Chemical formula 1]
[0021]
[0022] In formula (1-1), R 1 ~R 3 Each independently represents a hydrogen atom, a substituted or unsubstituted aliphatic hydrocarbon group, or a substituted or unsubstituted aromatic group, and R 1 ~R 3 At least two of them may be bonded to form a ring structure, R 1 ~R 3 does not contain an alkoxysilyl group as a substituent, when R 1 ~R 3 When at least one of them is a hydrogen atom, R 1 ~R 3 At least one of the other ones of represents a structure having a branched structure or a cyclic structure.
[0023] <2> The curable resin composition according to <1>, wherein the basic compound or its weak acid salt is at least one basic compound or its weak acid salt selected from the group consisting of aliphatic secondary amines, aliphatic tertiary amines, aromatic secondary amines, aromatic tertiary amines and nitrogen-containing heterocyclic compounds.
[0024] <3> The curable resin composition according to <1> or <2>, wherein the basic compound or a weak acid salt thereof is a monoamine compound or a weak acid salt thereof.
[0025] <4> The curable resin composition according to any one of <1> to <3>, wherein the content of the basic compound or its weak acid salt is 0.2 to 10% by mass based on the total solid content of the composition.
[0026] <5> The curable resin composition according to any one of <1> to <4>, wherein the basic compound or a weak acid salt thereof has a molecular weight of 60 to 200.
[0027] <6> The curable resin composition according to any one of <1> to <5>, wherein the resin is a polyimide precursor having a repeating unit represented by the following formula (1).
[0028] [Chemical formula 2]
[0029]
[0030] In formula (1), A 1 and A 2 Each independently represents an oxygen atom or NH, R 111 represents a divalent organic group, R 115 represents a tetravalent organic group, R 113 and R 114 Each independently represents a hydrogen atom or a monovalent organic group.
[0031] <7> The curable resin composition according to <6>, wherein the R 113 and R 114 At least one of the compounds comprises a free radical polymerizable group.
[0032] <8> The curable resin composition according to any one of <1> to <7>, wherein an acid value of the resin is 8 to 80 mgKOH / g.
[0033] <9> The curable resin composition according to any one of <1> to <8>, wherein a content of water is 5% by mass or less based on the total mass of the solvent.
[0034] <10> The curable resin composition according to any one of <1> to <9>, further comprising a radical polymerizable compound.
[0035] <11> The curable resin composition according to any one of <1> to <10>, further comprising at least one selected from the group consisting of an onium salt and a thermal base generator.
[0036] <12> The curable resin composition according to any one of <1> to <11>, which is used for forming an interlayer insulating film for a rewiring layer.
[0037] <13> A method for producing a curable resin composition, which is a method for producing the curable resin composition according to any one of <1> to <12>, the method comprising the following steps:
[0038] A composition containing the resin, the polymerization initiator, and the solvent and a basic compound represented by formula (1-1) or a weak acid salt thereof are mixed.
[0039] <14> A cured film formed by curing the curable resin composition according to any one of <1> to <12>.
[0040] <15> A laminate comprising two or more layers of the cured films according to <14>, wherein a metal layer is provided between any of the cured films.
[0041] <16> A method for producing a cured film, comprising: a film forming step of applying the curable resin composition according to any one of <1> to <12> to a substrate to form a film.
[0042] <17> The method for producing a cured film according to <16> comprises the following step before the film forming step: mixing a composition comprising the resin, the polymerization initiator and the solvent and a basic compound having a structure represented by formula (1-1) or a weak acid salt thereof to produce the curable resin composition.
[0043] <18> The method for producing a cured film according to <16> or <17>, comprising: an exposure step of exposing the film to light; and a development step of developing the film.
[0044] <19> The method for producing a cured film according to any one of <16> to <18>, comprising a heating step of heating the film at 50 to 450°C.
[0045] <20> A semiconductor device comprising the cured film according to <14> or the laminated body according to <15>.
[0046] Effects of the Invention
[0047] According to the present invention, there can be provided a curable resin composition having excellent film strength of the obtained cured film, a method for producing the above-mentioned curable resin composition, a cured film formed by curing the above-mentioned curable resin composition, a laminate including the above-mentioned cured film, a method for producing the above-mentioned cured film, and a semiconductor device including the above-mentioned cured film or the above-mentioned laminate. DETAILED DESCRIPTION
[0048] Hereinafter, the main embodiments of the present invention will be described. However, the present invention is not limited to the embodiments shown.
[0049] In the present specification, a numerical range expressed using a symbol such as “to” means a range including the numerical values described before and after “to” as the lower limit and the upper limit, respectively.
[0050] In this specification, the term "process" includes not only an independent process but also a process that can be clearly distinguished from other processes as long as the intended effect of the process can be achieved.
[0051] In the marking of groups (atomic groups) in this specification, the marking not indicating substituted or unsubstituted includes groups without substitution and also includes groups (atomic groups) with substitution. For example, "alkyl" includes not only alkyl groups without substitution (unsubstituted alkyl groups) but also alkyl groups with substitution (substituted alkyl groups).
[0052] In this specification, unless otherwise specified, "exposure" includes not only exposure using light but also exposure using particle beams such as electron beams and ion beams. In addition, examples of light used for exposure include bright line spectrum of mercury lamps, far ultraviolet rays represented by excimer lasers, extreme ultraviolet rays (EUV light), X-rays, electron beams, and other actinic rays or radiation.
[0053] In this specification, “(meth)acrylate” means both or either of “acrylate” and “methacrylate”, “(meth)acrylic acid” means both or either of “acrylic acid” and “methacrylic acid”, and “(meth)acryloyl” means both or either of “acryloyl” and “methacryloyl”.
[0054] In the present specification, Me in the structural formula represents a methyl group, Et represents an ethyl group, Bu represents a butyl group, and Ph represents a phenyl group.
[0055] In this specification, the total solid content refers to the total mass of the components after removing the solvent from all the components of the composition. In addition, in this specification, the solid content concentration is the mass percentage of the other components excluding the solvent relative to the total mass of the composition.
[0056] In this specification, as long as there is no special description, the weight average molecular weight (Mw) and the number average molecular weight (Mn) are defined as polystyrene conversion values according to gel permeation chromatography (GPC measurement). In this specification, the weight average molecular weight (Mw) and the number average molecular weight (Mn) can be obtained, for example, by using HLC-8220GPC (manufactured by TOSOH CORPORATION), and using protective columns HZ-L, TSKgel Super HZM-M, TSKgel Super HZ4000, TSKgel Super HZ3000, TSKgel Super HZ2000 (manufactured by TOSOH CORPORATION) as columns. As long as there is no special description, these molecular weights are set to be measured using THF (tetrahydrofuran) as an eluent. And, as long as there is no special description, the detection in the GPC measurement is set to a wavelength 254nm detector using UV line (ultraviolet rays).
[0057] In this specification, when the positional relationship of each layer constituting the laminate is recorded as "up" or "down", it is sufficient to have other layers on the upper side or lower side of the layer that becomes the reference among the multiple layers of interest. That is, a third layer or element may be further inserted between the layer that becomes the reference and the above-mentioned other layers, and the layer that becomes the reference and the above-mentioned other layers do not need to be in contact. In addition, unless otherwise specified, the direction of stacking layers on the substrate is referred to as "up", or, when there is a photosensitive layer, the direction from the substrate toward the photosensitive layer is referred to as "up", and the opposite direction is referred to as "down". In addition, the setting of this up and down direction is for the convenience of explaining this specification. In actual practice, the "up" direction in this specification may also be different from the vertical direction.
[0058] In this specification, unless otherwise specified, in the composition, as each component contained in the composition, two or more compounds corresponding to the component may be included. Furthermore, unless otherwise specified, the content of each component in the composition refers to the total content of all compounds corresponding to the component.
[0059] In this specification, unless otherwise specified, the temperature is 23° C. and the air pressure is 101,325 Pa (1 atmosphere).
[0060] In the present specification, a combination of preferred embodiments is a more preferred embodiment.
[0061] (Curable resin composition)
[0062] The curable resin composition of the present invention contains at least one resin selected from the group consisting of a polyimide precursor and a polybenzoxazole precursor, and a compound represented by the following formula (1-1) (hereinafter also referred to as a “specific compound”).
[0063] The curable resin composition of the present invention preferably contains a polymerizable compound, and more preferably contains a radical polymerizable compound.
[0064] Furthermore, the curable resin composition of the present invention preferably further contains at least one selected from the group consisting of onium salts and thermal base generators.
[0065] [Chemical formula 3]
[0066]
[0067] In formula (1-1), R 1 ~R 3 Each independently represents a hydrogen atom, a substituted or unsubstituted aliphatic hydrocarbon group, or a substituted or unsubstituted aromatic group, and R 1 ~R 3 At least two of them may be bonded to form a ring structure, R 1 ~R 3 does not contain an alkoxysilyl group as a substituent, when R 1 ~R 3 When at least one of them is a hydrogen atom, R 1 ~R 3 At least one of the other ones of represents a structure having a branched structure or a cyclic structure.
[0068] The cured film obtained from the curable resin composition of the present invention is excellent in film strength.
[0069] Although the mechanism by which the above-mentioned effects can be obtained is not clear, it is presumed as follows.
[0070] Conventionally, curable resin compositions containing polymer precursors are used for applications in which, after being applied to a substrate or the like, the precursors are cyclized by heating or the like to obtain cured films containing polyimide resins or the like.
[0071] Here, when a cured film is obtained by the above method, the film gradually solidifies as cyclization proceeds. Therefore, further cyclization may be difficult to occur due to, for example, restriction of movement of the structure included in the polymer precursor before cyclization in the film.
[0072] However, the curable resin composition of the present invention includes a specific compound. It is believed that the specific compound promotes the cyclization of the polymer precursor. In addition, it is believed that the specific compound of the structure represented by formula (1-1) is also easy to move in the film being cyclized, so even in the film being gradually cyclized, the further cyclization of the polymer precursor containing the heterocycle can be promoted. Through the above mechanism, according to the curable resin composition of the present invention, it is believed that the closed loop rate of the polymer precursor is improved, and a cured film with excellent film strength can be obtained.
[0073] Furthermore, according to the curable resin composition of the present invention, as described above, the ring closure rate is improved, and therefore a cured film having excellent chemical resistance can be easily obtained.
[0074] Furthermore, since the specific compound in the curable resin composition of the present invention has a specific structure, it is considered that the cyclization of the polymer precursor is less likely to be promoted when stored at 20° C., and the storage stability is also likely to be excellent.
[0075] When the curable resin composition is photosensitivity, for example, a composition film formed of the curable resin composition may be polymerized by exposure such as pattern exposure, and the polymer precursor may be cyclized by heating or the like after development.
[0076] Examples of the case where the curable resin composition has photosensitivity include the case where the polymer precursor has a polymerizable group, the curable resin composition contains a polymerizable compound, or both, and the polymerization initiator in the curable resin composition is a photopolymerization initiator.
[0077] When cyclization is performed in such a film after polymerization, the cyclization of the polymer precursor may be difficult to perform because the film is solidified by polymerization, and the movement of the structure included in the polymer precursor is restricted.
[0078] According to the curable resin composition of the present invention, even in the film after the polymerization of the polymerizable group, cyclization is promoted by the specific compound, so that the ring closure rate of the polymer precursor is improved, and a cured film with excellent film strength can be easily obtained.
[0079] In particular, when the exposure amount during the exposure is large and the degree of progress of the polymerization is large, it is considered that the curable resin composition of the present invention can easily obtain a cured film having excellent film strength due to the promotion of cyclization by the specific compound.
[0080] Here, Patent Documents 1 or 2 neither describe nor suggest a curable resin composition containing a polymer precursor containing a heterocyclic ring, a specific compound, a polymerization initiator, and a solvent.
[0081] Hereinafter, the components contained in the curable resin composition of the present invention will be described in detail.
[0082] <Polymer precursor containing heterocyclic ring>
[0083] The curable resin composition of the present invention contains a polymer precursor containing a heterocyclic ring.
[0084] The curable resin composition of the present invention contains at least one precursor selected from the group consisting of polyimide precursors and polybenzoxazole precursors as the heterocyclic ring-containing polymer precursor, and preferably contains a polyimide precursor.
[0085] 〔Polyimide precursor〕
[0086] From the viewpoint of the film strength of the obtained cured film, the polyimide precursor preferably has a repeating unit represented by the following formula (1).
[0087] [Chemical formula 4]
[0088]
[0089] In formula (1), A 1 and A 2 Each independently represents an oxygen atom or -NH-, R 111 represents a divalent organic group, R 115 represents a tetravalent organic group, R 113 and R 114 Each independently represents a hydrogen atom or a monovalent organic group.
[0090] -A 1 and A 2 -
[0091] A in formula (1) 1 and A 2 Each independently represents an oxygen atom or -NH-, and is preferably an oxygen atom.
[0092] -R 111 -
[0093] R in formula (1) 111 represents a divalent organic group. Examples of the divalent organic group include a linear or branched aliphatic group, a cyclic aliphatic group, an aromatic group, a heteroaromatic group, or a group composed of two or more thereof, preferably a linear aliphatic group having 2 to 20 carbon atoms, a branched aliphatic group having 3 to 20 carbon atoms, a cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a group composed of two or more thereof, and more preferably an aromatic group having 6 to 20 carbon atoms.
[0094] R in formula (1) 111 It is preferably derived from a diamine. Examples of the diamine used in the production of the polyimide precursor include linear or branched aliphatic, cyclic aliphatic or aromatic diamines. The diamine may be used alone or in combination of two or more.
[0095] Specifically, the diamine is preferably a diamine containing a linear aliphatic group having 2 to 20 carbon atoms, a branched or cyclic aliphatic group having 3 to 20 carbon atoms, an aromatic group having 6 to 20 carbon atoms, or a group combining two or more of these, and more preferably a diamine containing an aromatic group having 6 to 20 carbon atoms. Examples of the group containing an aromatic group include the following.
[0096] [Chemical formula 5]
[0097]
[0098] In the formula, A is preferably a single bond or an aliphatic hydrocarbon group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, -O-, -C(=O)-, -S-, or -S(=O). 2 -, -NHC(=O)-, or a group formed by combining two or more of these, more preferably a single bond, an alkylene group having 1 to 3 carbon atoms which may be substituted with a fluorine atom, -O-, -C(=O)-, -S- and S(=O) 2 - is further preferably selected from -CH 2 -、-O-、-S-、-S(=O) 2 -、-C(CF 3 ) 2 - and -C(CH 3 ) 2 - is a divalent group in the group consisting of.
[0099] The diamine may be, for example, at least one selected from the group consisting of 1,2-diaminoethane, 1,2-diaminopropane, 1,3-diaminopropane, 1,4-diaminobutane, and 1,6-diaminohexane; 1,2- or 1,3-diaminocyclopentane, 1,2-, 1,3- or 1,4-diaminocyclohexane, 1,2-, 1,3- or 1,4-bis(aminomethyl)cyclohexane, bis-(4-aminocyclohexyl)methane, bis-(3-aminocyclohexyl)methane, 4,4'-diamino-3,3'-dimethylcyclohexylmethane or isophoronediamine; m- or p-phenylenediamine, diaminotoluene, 4,4'- or 3,3'-diaminobiphenyl, 4,4'-diaminodiphenyl ether, 3,3'-diaminodiphenyl ether, 4,4'- or 3,3'-diaminodiphenylmethane, 4,4'- or 3,3'-diaminodiphenyl sulfone, 4,4'- or 3,3'-diaminodiphenyl sulfide, 4,4'- or 3,3'-diaminobenzophenone, 3,3'-dimethyl-4,4'-diaminobiphenyl, 2,2'-dimethyl-4,4'-diaminobiphenyl (4,4'-diamino-2,2'-dimethylbiphenyl), 3,3'-dimethoxy-4,4'-diaminobiphenyl, 2,2-bis(4-aminophenyl)propane, 2,2-bis(4-aminophenyl)hexafluoropropane, 2,2-bis(3-hydroxy-4-aminophenyl)propane, 2,2-bis(3-hydroxy-4-aminophenyl)hexafluoropropane, 2,2-bis(3-amino-4- 4-(2-aminophenoxy)phenyl)sulfone, 1,4-bis(4-aminophenoxy)benzene, 9,10-bis(4-aminophenyl)anthracene, 3,3'-dimethyl-4,4'-diaminodiphenylsulfone, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(3-aminophenoxy)benzene, 1,3-bis(4-aminophenyl)benzene, 3-(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 3- ...4-aminophenoxy)benzene, 3-(4-aminophenoxy)benzene, 1,3-bis(4-aminophenyl)benzene, 3-(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenyl)benzene, 3-(4-aminophenoxy)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenoxy)benzene, 1,3-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophenyl)benzene, 1,3-bis(4-aminophen ,3'-diethyl-4,4'-diaminodiphenylmethane, 3,3'-dimethyl-4,4'-diaminodiphenylmethane, 4,4'-diaminooctafluorobiphenyl, 2,2-bis[4-(4-aminophenoxy)phenyl]propane, 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane, 9,9-bis(4-aminophenyl)-10-hydroanthracene, 3,3',4,4'-tetraaminobiphenyl, 3,3',4,4'-tetraaminodiphenyl ether, 1,4-diaminoanthraquinone, 1,5-diaminoanthraquinone, 3,3-dihydroxy-4,4'-diaminobiphenyl, 9,9'-bis(4-aminophenyl)fluorene, 4,4'-dimethyl-3,3'-diaminodiphenyl sulfone, 3,3',5,5'-tetramethyl-4,4'-Diaminodiphenylmethane, 2-(3',5'-diaminobenzoyloxy)ethyl methacrylate, 2,4- or 2,5-diaminoisopropylbenzene, 2,5-dimethyl-p-phenylenediamine, ethylguanazine, 2,3,5,6-tetramethyl-p-phenylenediamine, 2,4,6-trimethyl-m-phenylenediamine, bis(3-aminopropyl)tetramethyldisiloxane, 2,7-diaminofluorene, 2,5-diaminopyridine, 1,2-bis(4-aminophenyl)ethane, Diaminobenzanilide, esters of diaminobenzoic acid, 1,5-diaminonaphthalene, diaminotrifluorotoluene, 1,3-bis(4-aminophenyl)hexafluoropropane, 1,4-bis(4-aminophenyl)octafluorobutane, 1,5-bis(4-aminophenyl)decafluoropentane, 1,7-bis(4-aminophenyl)tetradecafluoroheptane, 2,2-bis[4-(3-aminophenoxy)phenyl]hexafluoropropane, 2,2-bis[4-(2-aminophenoxy)phenyl]hexafluoro propane, 2,2-bis[4-(4-aminophenoxy)-3,5-dimethylphenyl]hexafluoropropane, 2,2-bis[4-(4-aminophenoxy)-3,5-bis(trifluoromethyl)phenyl]hexafluoropropane, p-bis(4-amino-2-trifluoromethylphenoxy)benzene, 4,4'-bis(4-amino-2-trifluoromethylphenoxy)biphenyl, 4,4'-bis(4-amino-3-trifluoromethylphenoxy)biphenyl, 4,4'-bis(4-amino- 2-trifluoromethylphenoxy) diphenyl sulfone, 4,4'-bis(3-amino-5-trifluoromethylphenoxy) diphenyl sulfone, 2,2-bis[4-(4-amino-3-trifluoromethylphenoxy)phenyl]hexafluoropropane, 3,3',5,5'-tetramethyl-4,4'-diaminobiphenyl, 4,4'-diamino-2,2'-bis(trifluoromethyl)biphenyl, 2,2',5,5',6,6'-hexafluorotriazine and 4,4'-diaminobiphenylene.
[0100] Furthermore, diamines (DA-1) to (DA-18) shown below are also preferred.
[0101] [Chemical formula 6]
[0102]
[0103] [Chemical formula 7]
[0104]
[0105] Furthermore, as a preferred example, a diamine having at least two alkylene glycol units in the main chain can also be cited. Preferably, the diamine contains two or more ethylene glycol chains or propylene glycol chains or both in total in one molecule, and more preferably, the diamine does not contain an aromatic ring. Specific examples include JEFFAMINE (registered trademark) KH-511, JEFFAMINE (registered trademark) ED-600, JEFFAMINE (registered trademark) ED-900, JEFFAMINE (registered trademark) ED-2003, JEFFAMINE (registered trademark) EDR-148, JEFFAMINE (registered trademark) EDR-176, D-200, D-400, D-2000, D-4000 (these are trade names, manufactured by HUNTSMAN), 1-(2-(2-(2-aminopropoxy)ethoxy)propoxy)propan-2-amine, and 1-(1-(1-(2-aminopropoxy)propan-2-yl)oxy)propan-2-amine, but are not limited to these.
[0106] The structures of JEFFAMINE (registered trademark) KH-511, JEFFAMINE (registered trademark) ED-600, JEFFAMINE (registered trademark) ED-900, JEFFAMINE (registered trademark) ED-2003, JEFFAMINE (registered trademark) EDR-148, and JEFFAMINE (registered trademark) EDR-176 are shown below.
[0107] [Chemical formula 8]
[0108]
[0109] In the above, x, y, and z are arithmetic means.
[0110] From the viewpoint of the flexibility of the obtained cured film, R in the formula (1) 111 Preferably, -Ar 0 -L 0 -Ar 0 - means. 0 Each of them is independently an aromatic hydrocarbon group (preferably having 6 to 22 carbon atoms, more preferably 6 to 18 carbon atoms, and particularly preferably 6 to 10 carbon atoms), and is preferably a phenylene group. 0 represents a single bond or an aliphatic hydrocarbon group having 1 to 10 carbon atoms which may be substituted with a fluorine atom, -O-, -C(=O)-, -S-, -S(=O) 2 -, -NHCO- or a group formed by combining two or more of these. 0 The meaning of the preferred range is the same as that of A above.
[0111] From the perspective of i-ray transmittance, R in formula (1) 111 Preferred are divalent organic groups represented by the following formula (51) or formula (61). In particular, from the viewpoint of i-ray transmittance and availability, divalent organic groups represented by formula (61) are more preferred.
[0112] [Chemical formula 9]
[0113]
[0114] In formula (51), R 50 ~R 57 are independently a hydrogen atom, a fluorine atom or a monovalent organic group, R 50 ~R 57 At least one of them is a fluorine atom, a methyl group, a fluoromethyl group, a difluoromethyl group or a trifluoromethyl group, and * independently represents a bonding position to other structures.
[0115] As R 50 ~R 57 Examples of the monovalent organic group include an unsubstituted alkyl group having 1 to 10 carbon atoms (preferably 1 to 6 carbon atoms) and a fluorinated alkyl group having 1 to 10 carbon atoms (preferably 1 to 6 carbon atoms).
[0116] [Chemical formula 10]
[0117]
[0118] In formula (61), R 58 and R 59 are each independently a fluorine atom, a fluoromethyl group, a difluoromethyl group or a trifluoromethyl group.
[0119] Examples of the diamine compound having the structure of formula (51) or (61) include dimethyl-4,4'-diaminobiphenyl, 2,2'-bis(trifluoromethyl)-4,4'-diaminobiphenyl, 2,2'-bis(fluoro)-4,4'-diaminobiphenyl, and 4,4'-diaminooctafluorobiphenyl. These may be used alone or in combination of two or more.
[0120] In addition, the following diamines can also be preferably used.
[0121] [Chemical formula 11]
[0122]
[0123] -R 115 -
[0124] R in formula (1) 115The tetravalent organic group is preferably a tetravalent organic group containing an aromatic ring, and more preferably a group represented by the following formula (5) or (6).
[0125] [Chemical formula 12]
[0126]
[0127] R 112 The meaning and preferred range are the same as A. * Each independently represents a bonding position to other structures.
[0128] Specifically, R in formula (1) 115 Examples of the tetravalent organic group include a tetracarboxylic acid residue remaining after removing the acid dianhydride group from tetracarboxylic dianhydride.
[0129] The tetracarboxylic dianhydride may be used alone or in combination of two or more. The tetracarboxylic dianhydride is preferably a compound represented by the following formula (7).
[0130] [Chemical formula 13]
[0131]
[0132] R 115 represents a tetravalent organic group. 115 The meaning of is the same as R in formula (1) 115 same.
[0133] Specific examples of tetracarboxylic dianhydrides include at least one selected from the group consisting of pyromellitic acid, pyromellitic dianhydride (PMDA), 3,3',4,4'-biphenyltetracarboxylic dianhydride (4,4'-diphthalic anhydride), 3,3',4,4'-diphenyl sulfide tetracarboxylic dianhydride, 3,3',4,4'-diphenyl sulfone tetracarboxylic dianhydride, 3,3',4,4'-benzophenone tetracarboxylic dianhydride, 3,3',4,4'-diphenylmethane tetracarboxylic dianhydride, 2,2',3,3'-diphenylmethane tetracarboxylic dianhydride, 2,3,3',4'-biphenyltetracarboxylic dianhydride, 2,3,3',4'-benzophenone tetracarboxylic dianhydride, 4,4'-oxydiphthalic dianhydride, 2,3,6,7-naphthalene tetracarboxylic dianhydride, 1,4,5,7-naphthalene tetracarboxylic dianhydride, 2,2',3,3'-diphenylmethane tetracarboxylic dianhydride, (3,4-dicarboxyphenyl) propane dianhydride, 2,2-bis(2,3-dicarboxyphenyl) propane dianhydride, 2,2-bis(3,4-dicarboxyphenyl) hexafluoropropane dianhydride, 1,3-diphenylhexafluoropropane-3,3,4,4-tetracarboxylic dianhydride, 1,4,5,6-naphthalenetetracarboxylic dianhydride, 2,2',3,3'-diphenyltetracarboxylic dianhydride, 3,4,9,10-perylenetetracarboxylic dianhydride, 1,2,4,5-naphthalenetetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, 1,8,9,10-phenanthrenetetracarboxylic dianhydride, 1,1-bis(2,3-dicarboxyphenyl)ethane dianhydride, 1,1-bis(3,4-dicarboxyphenyl)ethane dianhydride, 1,2,3,4-benzenetetracarboxylic dianhydride, and alkyl derivatives having 1 to 6 carbon atoms and alkoxy derivatives having 1 to 6 carbon atoms thereof.
[0134] Furthermore, as preferred examples, tetracarboxylic dianhydrides (DAA-1) to (DAA-5) shown below can also be mentioned.
[0135] [Chemical formula 14]
[0136]
[0137] -R 113 and R 114 -
[0138] R in formula (1) 113 and R 114 Each independently represents a hydrogen atom or a monovalent organic group. As the monovalent organic group, it is preferred to include a linear or branched alkyl group, a cyclic alkyl group, an aromatic group or a polyalkyleneoxy group, and more preferably to include a polyalkyleneoxy group. 113 and R 114 At least one of the two or more preferably both of them contain a radical polymerizable group. The radical polymerizable group is a group that can undergo a crosslinking reaction by the action of a radical, and a preferred example is a group having an ethylenically unsaturated bond.
[0139] Examples of the group having an ethylenically unsaturated bond include a group having a vinyl group directly bonded to an aromatic ring such as a vinyl group, an allyl group, and a vinylphenyl group which may be substituted, a (meth)acryloyl group, and a group represented by the following formula (III).
[0140] [Chemical formula 15]
[0141]
[0142] In formula (III), R 200 It represents a hydrogen atom, a methyl group, an ethyl group or a hydroxymethyl group, and is preferably a hydrogen atom or a methyl group.
[0143] In formula (III), R 201 represents an alkylene group having 2 to 12 carbon atoms, -CH 2 CH(OH)CH 2 - or a (poly)oxyalkylene group having 4 to 30 carbon atoms (the alkylene group preferably has 1 to 12 carbon atoms, more preferably 1 to 6, and particularly preferably 1 to 3 carbon atoms; and the number of repetitions is preferably 1 to 12, more preferably 1 to 6, and particularly preferably 1 to 3). In addition, the (poly)oxyalkylene group refers to an oxyalkylene group or a polyoxyalkylene group.
[0144] Preferred R 201 Examples of alkylene groups include ethylene, propylene, trimethylene, tetramethylene, 1,2-butanediyl, 1,3-butanediyl, pentamethylene, hexamethylene, octamethylene, dodecamethylene, and the like; -CH 2 CH(OH)CH 2 -, more preferably ethylene, propylene, trimethylene, -CH 2 CH(OH)CH 2 -.
[0145] R is particularly preferred 200 is methyl and R 201 For ethylene.
[0146] In formula (III), * indicates a bonding position with other structures.
[0147] Regarding a preferred embodiment of the polyimide precursor in the present invention, as R 113 or R 114 The monovalent organic group may include aliphatic groups, aromatic groups, and arylalkyl groups having 1, 2, or 3, preferably 1, acid groups. Specifically, aromatic groups having 6 to 20 carbon atoms and arylalkyl groups having 7 to 25 carbon atoms may be mentioned. More specifically, phenyl groups having acid groups and benzyl groups having acid groups may be mentioned. The acid groups are preferably hydroxyl groups. That is, R 113or R 114 A group having a hydroxyl group is preferred.
[0148] As R 113 or R 114 The monovalent organic group represented by the above-mentioned may preferably have a substituent that improves the solubility in a developer.
[0149] From the viewpoint of solubility in aqueous developer, R 113 or R 114 It is a hydrogen atom, a benzyl group, a 2-hydroxybenzyl group, a 3-hydroxybenzyl group or a 4-hydroxybenzyl group.
[0150] From the perspective of solubility in organic solvents, R 113 or R 114 A monovalent organic group is preferred. The monovalent organic group is preferably a linear or branched alkyl group, a cyclic alkyl group, or an aromatic group, and more preferably an alkyl group substituted with an aromatic group.
[0151] The number of carbon atoms of the alkyl group is preferably 1 to 30 (3 or more in the case of a ring). The alkyl group may be any of a straight chain, a branched chain, or a cyclic chain. Examples of straight chain or branched chain alkyl groups include methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, dodecyl, tetradecyl, octadecyl, isopropyl, isobutyl, sec-butyl, tert-butyl, 1-ethylpentyl, and 2-ethylhexyl. The cyclic alkyl group may be a monocyclic cyclic alkyl group or a polycyclic cyclic alkyl group. Examples of monocyclic cyclic alkyl groups include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, and cyclooctyl. Examples of polycyclic cyclic alkyl groups include adamantyl, norbornyl, bornyl, camphorenyl, decahydronaphthyl, tricyclodecanyl, tetracyclodecanyl, camphoryl, dicyclohexyl, and pinenyl. Furthermore, the alkyl group substituted with an aromatic group is preferably a linear alkyl group substituted with an aromatic group as described below.
[0152] The aromatic group is specifically a substituted or unsubstituted aromatic hydrocarbon group (the cyclic structure constituting the group includes a benzene ring, a naphthalene ring, a biphenyl ring, a fluorene ring, a pentalene ring, an indene ring, an azulene ring, a heptalene ring, an indenyl ring, a perylene ring, a condensed pentaphenyl ring, an acenaphthylene ring, a phenanthrene ring, an anthracene ring, a condensed benzene ring, a substituted or unsubstituted aromatic heterocyclic group (the cyclic structure constituting the group is a fluorene ring, a pyrrole ring, a furan ring, a thiophene ring, an imidazole ring, an oxazole ring, a thiazole ring, a pyridine ring, a pyrazine ring, a pyrimidine ring, a pyridazine ring, an indolizine ring, an indole ring, a benzofuran ring, a benzothiophene ring, an isobenzofuran ring, a quinolizine ring, a quinoline ring, a phthalazine ring, a naphthyridine ring, a quinoxaline ring, a quinoxazoline ring, an isoquinoline ring, a carbazole ring, a phenanthridine ring, an acridine ring, a phenanthroline ring, a thianthracene ring, a chromene ring, a xanthene ring, a phenoxathiol ring, a phenothiazine ring or a phenazine ring).
[0153] Furthermore, the polyimide precursor also preferably has fluorine atoms in the repeating unit. The fluorine atom content in the polyimide precursor is preferably 10% by mass or more, more preferably 20% by mass or more. The upper limit is not particularly limited, but is practically 50% by mass or less.
[0154] Furthermore, in order to improve the adhesion to the substrate, an aliphatic group having a siloxane structure may be copolymerized with the repeating unit represented by formula (1). Specifically, examples of the diamine component include bis(3-aminopropyl)tetramethyldisiloxane and bis(p-aminophenyl)octamethylpentasiloxane.
[0155] The repeating unit represented by formula (1) is preferably a repeating unit represented by formula (1-A) or formula (1-B).
[0156] [Chemical formula 16]
[0157]
[0158] A 11 and A 12 represents an oxygen atom or -NH-, R 111 and R 112 Each independently represents a divalent organic group, R 113 and R 114 Each independently represents a hydrogen atom or a monovalent organic group, R 113 and R 114 At least one of the groups is preferably a group containing a radical polymerizable group, and more preferably a radical polymerizable group.
[0159] A 11 , A 12 , R 111 , R 113 and R 114 The preferred ranges of are respectively the same as those of A in formula (1). 1 , A 2 , R 111 , R 113 and R 114 The preferred range is the same.
[0160] R 112 The preferred range of is the same as that of R in formula (5) 112 The same, among which an oxygen atom is more preferred.
[0161] The bonding positions of the carbonyl group to the benzene ring in the formula are preferably 4, 5, 3', 4' in the formula (1-A) and 1, 2, 4, 5 in the formula (1-B).
[0162] In the polyimide precursor, the repeating unit represented by formula (1) may be one type, or may be two or more types. Furthermore, the repeating unit represented by formula (1) may contain structural isomers. Furthermore, the polyimide precursor may contain other types of repeating units in addition to the repeating unit of formula (1).
[0163] One embodiment of the polyimide precursor in the present invention includes a polyimide precursor in which 50 mol % or more, further 70 mol % or more, and particularly 90 mol % or more of all repeating units are repeating units represented by formula (1). The upper limit is practically 100 mol % or less.
[0164] The weight average molecular weight (Mw) of the polyimide precursor is preferably 2,000 to 500,000, more preferably 5,000 to 100,000, and further preferably 10,000 to 50,000. The number average molecular weight (Mn) is preferably 800 to 250,000, more preferably 2,000 to 50,000, and further preferably 4,000 to 25,000.
[0165] The molecular weight dispersion of the polyimide precursor is preferably 1.5 to 7.0, more preferably 1.8 to 6.5.
[0166] The molecular weight dispersion of the polyimide precursor is preferably 1.5 to 3.5, more preferably 2 to 3.
[0167] In this specification, the molecular weight dispersion refers to a value obtained by dividing the weight average molecular weight by the number average molecular weight (weight average molecular weight / number average molecular weight).
[0168] The polyimide precursor is obtained by reacting dicarboxylic acid or a dicarboxylic acid derivative with diamine, and is preferably obtained by halogenating dicarboxylic acid or a dicarboxylic acid derivative with a halogenating agent and then reacting with diamine.
[0169] In the method for producing a polyimide precursor, it is preferred to use an organic solvent when performing the reaction. The organic solvent may be one kind or two or more kinds.
[0170] The organic solvent can be appropriately determined according to the raw material, and examples thereof include pyridine, diethylene glycol dimethyl ether (diglyme), N-methyl-2-pyrrolidone, and N-ethyl-2-pyrrolidone.
[0171] In the method for producing a polyimide precursor, in order to further improve storage stability, it is preferred to seal the ends of the polyimide precursor with an end-capping agent such as an acid anhydride, a monocarboxylic acid, a monoacyl chloride compound, or a monoactive ester compound. As the end-capping agent, monohydric alcohols, phenols, thiols, thiophenols, or monoamines are more preferably used.
[0172] Preferred monohydric alcohols include primary alcohols such as methanol, ethanol, propanol, butanol, hexanol, octanol, dodecynol, benzyl alcohol, 2-phenylethanol, 2-methoxyethanol, 2-chloromethanol, and furfuryl alcohol, secondary alcohols such as isopropanol, 2-butanol, cyclohexanol, cyclopentanol, and 1-methoxy-2-propanol, and tertiary alcohols such as tertiary butanol and adamantane alcohol. Preferred phenols include phenol, methoxyphenol, methylphenol, naphthalen-1-ol, and naphthalen-2-ol.
[0173] Preferred monoamine compounds include aniline, 2-ethynylaniline, 3-ethynylaniline, 4-ethynylaniline, 5-amino-8-hydroxyquinoline, 1-hydroxy-7-aminonaphthalene, 1-hydroxy-6-aminonaphthalene, 1-hydroxy-5-aminonaphthalene, 1-hydroxy-4-aminonaphthalene, 2-hydroxy-7-aminonaphthalene, 2-hydroxy-6-aminonaphthalene, 2-hydroxy-5-aminonaphthalene, 1-carboxy-7-aminonaphthalene, 1-carboxy-6-aminonaphthalene, 1-carboxy-5-aminonaphthalene, 2 -carboxy-7-aminonaphthalene, 2-carboxy-6-aminonaphthalene, 2-carboxy-5-aminonaphthalene, 2-aminobenzoic acid, 3-aminobenzoic acid, 4-aminobenzoic acid, 4-aminosalicylic acid, 5-aminosalicylic acid, 6-aminosalicylic acid, 2-aminobenzenesulfonic acid, 3-aminobenzenesulfonic acid, 4-aminobenzenesulfonic acid, 3-amino-4,6-dihydroxypyrimidine, 2-aminophenol, 3-aminophenol, 4-aminophenol, 2-aminothiophenol, 3-aminothiophenol, 4-aminothiophenol, etc. Two or more of these can be used, and a plurality of different terminal groups can be introduced by reacting a plurality of end-capping agents.
[0174] Furthermore, when sealing the amino group at the end of the resin, it is possible to seal with a compound having a functional group that can react with the amino group. Preferred sealants for amino groups are preferably carboxylic anhydride, carboxylic acid chloride, carboxylic acid bromide, sulfonyl chloride, sulfonic anhydride, sulfonic acid carboxylic anhydride, etc., more preferably carboxylic anhydride, carboxylic acid chloride. As preferred compounds of carboxylic anhydride, acetic anhydride, propionic anhydride, oxalic anhydride, succinic anhydride, maleic anhydride, phthalic anhydride, benzoic anhydride, etc. can be cited. Furthermore, as preferred compounds of carboxylic acid chloride, acetyl chloride, acryloyl chloride, propionyl chloride, methacryloyl chloride, pivaloyl chloride, cyclohexanecarbonyl chloride, 2-ethylhexanoyl chloride, cinnamoyl chloride, 1-adamantanecarbonyl chloride, heptafluorobutyryl chloride, stearyl chloride, benzoyl chloride, etc. can be cited.
[0175] When producing a polyimide precursor, it is preferable to include a step of precipitating a solid. Specifically, a polyimide precursor in a reaction solution is precipitated in water, and then dissolved in a solvent such as tetrahydrofuran in which the polyimide precursor is soluble, thereby precipitating a solid.
[0176] 〔Polybenzoxazole precursor〕
[0177] The polybenzoxazole precursor preferably includes a repeating unit represented by the following formula (2).
[0178] [Chemical formula 17]
[0179]
[0180] In formula (2), R 121 represents a divalent organic group, R 122 represents a tetravalent organic group, R 123 and R 124 Each independently represents a hydrogen atom or a monovalent organic group.
[0181] -R 121 -
[0182] In formula (2), R 121 The divalent organic group is preferably a group containing at least one of an aliphatic group (preferably having 1 to 24 carbon atoms, more preferably 1 to 12, and particularly preferably 1 to 6 carbon atoms) and an aromatic group (preferably having 6 to 22 carbon atoms, more preferably 6 to 14, and particularly preferably 6 to 12 carbon atoms). 121 The aromatic group may be R 111 As the above-mentioned aliphatic group, a straight-chain aliphatic group is preferred. 121 Preferably, it is derived from 4,4'-oxydibenzoyl chloride.
[0183] -R 122 -
[0184] In formula (2), R 122 The tetravalent organic group has the same meaning as R in the above formula (1). 115 The same, the preferred range is also the same. 122 Preferably, it is derived from 2,2'-bis(3-amino-4-hydroxyphenyl)hexafluoropropane.
[0185] -R 123 and R 124 -
[0186] R 123 and R 124 Each independently represents a hydrogen atom or a monovalent organic group, and has the same meaning as R in the above formula (1). 113 and R 114 The preferred ranges are the same.
[0187] The polybenzoxazole precursor may contain other types of repeating units in addition to the repeating unit of the above formula (2).
[0188] From the viewpoint of being able to suppress the occurrence of warping of the cured film due to ring closure, the polybenzoxazole precursor preferably further includes a diamine residue represented by the following formula (SL) as another type of repeating unit.
[0189] [Chemical formula 18]
[0190]
[0191] Z has structure a and structure b, R 1s is a hydrogen atom or a hydrocarbon group having 1 to 10 carbon atoms (preferably 1 to 6 carbon atoms, more preferably 1 to 3 carbon atoms), R 2s is a hydrocarbon group having 1 to 10 carbon atoms (preferably 1 to 6 carbon atoms, more preferably 1 to 3 carbon atoms), R 3s , R 4s , R 5s , R 6s At least one of them is an aromatic group (preferably having 6 to 22 carbon atoms, more preferably 6 to 18 carbon atoms, and particularly preferably 6 to 10 carbon atoms), and the rest are hydrogen atoms or organic groups having 1 to 30 carbon atoms (preferably 1 to 18 carbon atoms, more preferably 1 to 12 carbon atoms, and particularly preferably 1 to 6 carbon atoms), which may be the same or different. The polymerization of structure a and structure b may be block polymerization or random polymerization. In the Z portion, structure a is preferably 5 to 95 mol%, structure b is 95 to 5 mol%, and a+b is 100 mol%.
[0192] In formula (SL), preferred Z includes R in structure b. 5s and R 6s A substance containing phenyl. Furthermore, the molecular weight of the structure represented by formula (SL) is preferably 400 to 4,000, and more preferably 500 to 3,000. The molecular weight can be determined by gel permeation chromatography, which is generally used. By setting the molecular weight within the above range, the elastic modulus of the polybenzoxazole precursor after dehydration ring closure can be reduced, and the effect of suppressing warping and the effect of improving solubility can be taken into account.
[0193] When the polybenzoxazole precursor contains a diamine residue represented by formula (SL) as another type of repeating unit, it is preferred to further contain a tetracarboxylic acid residue remaining after removing the dianhydride group from tetracarboxylic dianhydride as a repeating unit from the viewpoint of improving the alkali solubility of the curable resin composition. Examples of such a tetracarboxylic acid residue include R in formula (1): 115 Example.
[0194] The weight average molecular weight (Mw) of the polybenzoxazole precursor is preferably 2,000 to 500,000, more preferably 5,000 to 100,000, and further preferably 10,000 to 50,000. The number average molecular weight (Mn) is preferably 800 to 250,000, more preferably 2,000 to 50,000, and further preferably 4,000 to 25,000.
[0195] The molecular weight dispersion of the polybenzoxazole precursor is preferably 1.5 to 3.5, more preferably 2 to 3.
[0196] -Acid value-
[0197] From the viewpoint of the film strength of the obtained cured film, the acid value of the polymer precursor containing a heterocyclic ring is preferably 80 mgKOH / g or less, more preferably 50 mgKOH / g or less, further preferably 30 mgKOH / g or less, and particularly preferably 20 mgKOH / g or less. Furthermore, the lower limit of the acid value is preferably 5 mgKOH / g or more, more preferably 8 mgKOH / g or more, and more preferably 10 mgKOH / g or more.
[0198] It is considered that when the acid value is within the above range, neutralization of the specific compound by the acid group can be suppressed, and cyclization of the polymer precursor containing a heterocyclic ring can be further facilitated.
[0199] The acid value is measured by a known method, for example, by the method described in JIS K 0070:1992.
[0200] The content of the polymer precursor containing a heterocyclic ring in the curable resin composition of the present invention is preferably 20% by mass or more, more preferably 30% by mass or more, further preferably 40% by mass or more, further preferably 50% by mass or more, further preferably 60% by mass or more, and further preferably 70% by mass or more, relative to the total solid content of the curable resin composition. In addition, the content of the polymer precursor containing a heterocyclic ring in the curable resin composition of the present invention is preferably 99.5% by mass or less, more preferably 99% by mass or less, further preferably 98% by mass or less, further preferably 97% by mass or less, and further preferably 95% by mass or less, relative to the total solid content of the curable resin composition.
[0201] The curable resin composition of the present invention may contain only one type of heterocyclic ring-containing polymer precursor or two or more types. When containing two or more types, the total amount is preferably within the above range.
[0202] <Specified compounds>
[0203] The curable resin composition of the present invention contains a basic compound represented by formula (1-1) or a weak acid salt thereof (specific compound).
[0204] In the present invention, the weak acid salt is preferably a salt that is alkaline in the curable resin composition of the present invention. Examples of the weak acid salt include carbonates, acetates, oxalates, and borates.
[0205] 〔pKa〕
[0206] The pKa of the conjugate acid of the specific compound (when the specific compound is a weak acid salt, the pKa of the conjugate acid of the basic compound dissociated from the weak acid salt) is preferably 1-7, more preferably 2-6, and even more preferably 2-5.
[0207] The pKa of the conjugate acid is taken into account the dissociation reaction of releasing hydrogen ions from the acid and the equilibrium constant Ka is expressed by its negative common logarithm pKa. The smaller the pKa, the stronger the acid. Unless otherwise specified, the pKa is set to the calculated value based on ACD / ChemSketch (registered trademark). Alternatively, the value published in the "Revised 5th Edition Chemistry Handbook Basics" compiled by the Chemical Society of Japan can be referred to.
[0208] 〔R 1 ~R 3 〕
[0209] In formula (1-1), R 1 ~R 3 Each independently represents a hydrogen atom, a substituted or unsubstituted aliphatic hydrocarbon group, or a substituted or unsubstituted aromatic group, and R 1 ~R 3At least two of them may be bonded to form a ring structure, R 1 ~R 3 does not contain an alkoxysilyl group as a substituent, when R 1 ~R 3 When at least one of them is a hydrogen atom, R 1 ~R 3 At least one of the other ones of represents a structure having a branched structure or a cyclic structure.
[0210] In the present specification, when simply described as "alkyl", it is considered that all alkyl groups formed of linear, branched, cyclic or a combination of these are included.
[0211] In formula (1-1), R 1 ~R 3 Each independently is preferably a hydrogen atom, a substituted or unsubstituted alkyl group, or a substituted or unsubstituted aromatic heterocyclic group, and more preferably a substituted or unsubstituted alkyl group, or a substituted or unsubstituted aromatic heterocyclic group.
[0212] As the above R 1 ~R 3 The aliphatic hydrocarbon group in is preferably an alkyl group having 1 to 20 carbon atoms, more preferably a straight-chain alkyl group having 1 to 10 carbon atoms, a branched-chain alkyl group having 3 to 10 carbon atoms, or a cyclic alkyl group having 3 to 10 carbon atoms, further preferably a straight-chain alkyl group having 1 to 4 carbon atoms, a branched-chain alkyl group having 3 to 6 carbon atoms, or a cyclohexyl group.
[0213] As the above R 1 ~R 3 The substituents of the alkyl group in the above-mentioned group include aromatic hydrocarbon groups (preferably phenyl groups), aromatic heterocyclic groups (preferably nitrogen-containing aromatic heterocyclic groups such as imidazolyl and pyridyl groups), alkoxy groups, alkoxycarbonyl groups, aryloxycarbonyl groups, vinyl groups, allyl groups, (meth)acrylamide groups, methacryloxy groups and other polymerizable groups.
[0214] As the above R 1 ~R 3 The aromatic group in is preferably an aromatic heterocyclic group having 5 to 6 ring members, and more preferably an aromatic heterocyclic group having 6 ring members. Furthermore, when the aromatic group is an aromatic heterocyclic group, it is preferred that the bonding position to the nitrogen atom in the aromatic heterocyclic group is a carbon atom. Furthermore, the aromatic heterocyclic group may include an aromatic heterocyclic group containing an oxygen atom, a nitrogen atom, a sulfur atom, a silicon atom, etc. as a heteroatom, and is preferably a nitrogen-containing aromatic heterocyclic group, and more preferably a 4-pyridyl group.
[0215] As the above R 1 ~R 3The substituent of the aromatic group in the above-mentioned alkyl group may be an alkyl group or a substituent of the above-mentioned alkyl group. In addition, as the substituent of the above-mentioned aromatic group, it is preferred that the substituent does not contain an amino group or a substituted amino group.
[0216] In formula (1-1), R is preferably 1 ~R 3 All of them are not hydrogen atoms or only one is a hydrogen atom.
[0217] When R 1 ~R 3 When at least one of them is a hydrogen atom, it is preferred that R 1 ~R 3 At least one of the other ones represents a structure having a branched structure or a cyclic structure, and the other two both represent a branched structure or a cyclic structure.
[0218] The structure having the branched structure is preferably a branched alkyl group, more preferably a branched alkyl group having 3 to 10 carbon atoms, further preferably a branched alkyl group having 3 to 6 carbon atoms, and particularly preferably an isopropyl group.
[0219] Examples of the structure having the cyclic structure include an alkyl group having a cyclic structure or the substituted or unsubstituted aromatic group described above, preferably an alkyl group having a cyclic structure having 6 to 20 carbon atoms, more preferably a cycloalkyl group having 6 to 20 carbon atoms, and still more preferably a cyclohexyl group.
[0220] In formula (1-1), R 1 ~R 3 At least two of them may be bonded to form a ring structure, and the ring structure to be formed may be any of an aliphatic heterocyclic structure and an aromatic heterocyclic structure.
[0221] The aliphatic heterocyclic structure is preferably an aliphatic heterocyclic structure having 5 or 6 ring members, more preferably a piperidine ring structure, a piperazine ring structure, or a morpholine ring structure, and still more preferably a piperidine ring structure.
[0222] The aromatic heterocyclic structure is preferably an aromatic heterocyclic structure having 5 or 6 ring members, such as an imidazole ring structure, a pyridine ring structure, a pyrimidine ring structure, a pyrazine ring structure, or a pyridazine ring structure, and more preferably an imidazole ring structure.
[0223] Furthermore, the above ring structure may further have a substituent, and examples of the substituent include 1 ~R 3 The substituents of the aromatic group in the same group.
[0224] R 1 ~R 3The ring structure formed by at least two bonds in the above-mentioned ring structure can be further fused with other ring structures. As the above-mentioned other ring structures, aliphatic hydrocarbon ring structures, aromatic hydrocarbon ring structures, aliphatic heterocyclic structures or aromatic heterocyclic structures can be mentioned, preferably aromatic hydrocarbon ring structures or aliphatic heterocyclic structures. As compounds represented by formula (1-1) having such a fused ring structure, 1,2-benzopyrazole, 1,3,4,6,7,8-hexahydro-1-methyl-2H-pyrimido[1,2-a]pyrimidine, etc. can be mentioned.
[0225] 〔Structure of a specific compound〕
[0226] From the viewpoint of improving the film strength of the obtained cured film, the specific compound is preferably at least one basic compound selected from the group consisting of aliphatic secondary amines, aliphatic tertiary amines, aromatic secondary amines, aromatic tertiary amines and nitrogen-containing heterocyclic compounds, or a weak acid salt thereof.
[0227] Among these, from the viewpoint of improving the film strength of the obtained cured film, aliphatic secondary amines or aromatic secondary amines are preferred.
[0228] Furthermore, from the viewpoint of improving the storage stability of the composition, an aliphatic tertiary amine, an aromatic tertiary amine or a nitrogen-containing heterocyclic compound is preferred.
[0229] In this specification, aliphatic amine refers to three structures (i.e., R 1 ~R 3 ) wherein at least one is an aliphatic hydrocarbon group and the remaining two are independently a hydrogen atom or an aliphatic hydrocarbon group.
[0230] The aliphatic secondary amine refers to a substance in which one of the three amine structures bonded to is a hydrogen atom and the remaining two are aliphatic hydrocarbon groups. Furthermore, when the specific compound is an aliphatic secondary amine, at least one of the aliphatic hydrocarbon groups has a branched structure or a cyclic structure, and preferably all of the aliphatic hydrocarbon groups have a branched structure or a cyclic structure.
[0231] The aliphatic tertiary amine refers to a substance in which all three structures bonded to the amine are aliphatic hydrocarbon groups.
[0232] The preferred embodiment of the aliphatic hydrocarbon group in the description of the aliphatic amine, aliphatic secondary amine or aliphatic tertiary amine is the same as that of the above R 1 ~R 3 The preferred embodiment of the aliphatic hydrocarbon group in is the same as that of the aliphatic hydrocarbon group in the above-mentioned aliphatic hydrocarbon group.
[0233] Furthermore, at least two of the aliphatic hydrocarbon groups in the aliphatic secondary amine or the aliphatic tertiary amine may be bonded to form a ring structure. Examples of the ring structure to be formed include an aliphatic heterocyclic structure.
[0234] In this specification, an aromatic amine refers to a structure in which three groups (i.e., R 1 ~R 3 ) in which at least one is an aromatic group and the other two are independently a hydrogen atom, an aliphatic hydrocarbon group or an aromatic group.
[0235] The aromatic secondary amine refers to a substance in which only one of the three structures bonded to the amine is a hydrogen atom, another one is an aromatic group, and the remaining one is an aliphatic hydrocarbon group or an aromatic group.
[0236] The aromatic tertiary amine refers to a substance in which one of the three structures bonded to the amine is an aromatic group and the other two are aliphatic hydrocarbon groups or aromatic groups.
[0237] Furthermore, when the aliphatic tertiary amine has two aliphatic hydrocarbon groups, these groups may be bonded to form a ring structure. Examples of the ring structure to be formed include an aliphatic heterocyclic structure.
[0238] The preferred embodiment of the aliphatic hydrocarbon group or aromatic group in the description of the aromatic amine, aromatic secondary amine or aromatic tertiary amine is the same as that of the above R 1 ~R 3 The preferred embodiments of the aliphatic hydrocarbon group or aromatic group in are the same. The above-mentioned aliphatic hydrocarbon group or aromatic group may further have the above-mentioned substituent.
[0239] -Aliphatic Secondary Amines-
[0240] As the secondary aliphatic amine, a dialkylamine is preferred.
[0241] In the present specification, dialkylamine refers to an amine compound in which one hydrogen atom and two alkyl groups are bonded to a nitrogen atom. The two alkyl groups in the dialkylamine may be bonded to form an aliphatic heterocyclic structure.
[0242] Of the two alkyl groups in the dialkylamine, at least one is preferably a branched alkyl group or an alkyl group having a cyclic structure, and both are more preferably branched alkyl groups or both are alkyl groups having a cyclic structure.
[0243] Preferred embodiments of the branched alkyl group are the same as preferred embodiments of the branched alkyl group in the structure having a branched structure.
[0244] Preferred embodiments of the alkyl group having a cyclic structure are the same as preferred embodiments of the alkyl group having a cyclic structure in the structure having a cyclic structure.
[0245] -Aliphatic tertiary amines-
[0246] The aliphatic tertiary amine is preferably a trialkylamine or an N-alkyl nitrogen-containing aliphatic heterocyclic compound.
[0247] In the present specification, trialkylamine refers to an amine compound in which three alkyl groups are bonded to a nitrogen atom. At least two alkyl groups in the trialkylamine may be bonded to form an aliphatic heterocyclic structure.
[0248] The three alkyl groups in the trialkylamine may be any of a linear alkyl group, a branched alkyl group or an alkyl group having a cyclic structure, and preferably all of them are linear alkyl groups.
[0249] The linear alkyl group is preferably a linear alkyl group having 1 to 20 carbon atoms, more preferably a linear alkyl group having 1 to 10 carbon atoms, and still more preferably a linear alkyl group having 1 to 4 carbon atoms.
[0250] Preferred embodiments of the branched alkyl group or the alkyl group having a cyclic structure are the same as preferred embodiments of the branched alkyl group or the alkyl group having a cyclic structure in the dialkylamine.
[0251] In this specification, N-alkyl nitrogen-containing aliphatic heterocyclic compounds refer to compounds in which the hydrogen atoms bonded to the nitrogen atoms in nitrogen-containing heterocyclic structures such as piperidine ring structure, piperazine ring structure and morpholine ring are substituted by alkyl groups. One of the nitrogen atoms contained in these nitrogen-containing heterocyclic structures is the nitrogen atom described in the above formula (1-1).
[0252] The alkyl group is preferably the same as the linear alkyl group, branched alkyl group or alkyl group having a cyclic structure in the trialkylamine. Among these, a branched alkyl group is more preferred.
[0253] Furthermore, the nitrogen-containing heterocyclic structure is preferably a nitrogen-containing heterocyclic structure having 5 to 10 ring members, and more preferably a nitrogen-containing heterocyclic structure having 6 ring members.
[0254] The nitrogen-containing heterocyclic structure is preferably a nitrogen-containing saturated heterocyclic structure.
[0255] The number of nitrogen atoms in the nitrogen-containing heterocyclic structure is preferably 1 or 2, and more preferably 1.
[0256] The nitrogen-containing heterocyclic structure may contain a hetero atom other than a nitrogen atom, but preferably contains no hetero atom other than a nitrogen atom.
[0257] The nitrogen-containing heterocyclic structure is preferably a pyridine ring or a morpholine ring structure.
[0258] -Aromatic secondary amines-
[0259] Examples of the aromatic secondary amine include diarylamine and alkylarylamine.
[0260] In the present specification, diarylamine refers to an amine compound in which one hydrogen atom and two aromatic groups are bonded to a nitrogen atom.
[0261] In the present specification, the alkylarylamine refers to an amine compound in which one hydrogen atom, one alkyl group, and one aromatic group are bonded to a nitrogen atom.
[0262] The aromatic group in the diarylamine or the alkylarylamine is preferably an aromatic group that is identical to R 1 ~R 3 The same group as the aromatic group in .
[0263] The alkyl group in the alkylarylamine is preferably the same group as the alkyl group in the trialkylamine.
[0264] -Aromatic tertiary amines-
[0265] Examples of the aromatic tertiary amine include dialkylmonoarylamines, monoalkyldiarylamines, and triarylamines. Among these, dialkylmonoarylamines are preferred from the viewpoint of film strength of the resulting cured film.
[0266] In the present specification, a dialkylmonoarylamine refers to an amine compound in which two alkyl groups and one aromatic group are bonded to a nitrogen atom. The two alkyl groups in the dialkylmonoarylamine may be bonded to form an aliphatic heterocyclic structure.
[0267] In the present specification, the monoalkyldiarylamine refers to an amine compound in which one alkyl group and two aromatic groups are bonded to a nitrogen atom.
[0268] In the present specification, triarylamine refers to an amine compound in which three aromatic groups are bonded to a nitrogen atom.
[0269] The aromatic group in the dialkylmonoarylamine, the monoalkyldiarylamine or the triarylamine is preferably an aromatic group that is identical to R in the formula (1-1). 1 ~R 3 The same group as the aromatic group in .
[0270] The alkyl group in the dialkylmonoarylamine or the monoalkyldiarylamine is preferably the same group as the alkyl group in the trialkylamine.
[0271] -Nitrogen-containing heterocyclic compounds-
[0272] The nitrogen-containing heterocyclic compound may be a nitrogen-containing aromatic heterocyclic compound or a nitrogen-containing aliphatic heterocyclic compound, but is preferably a nitrogen-containing aromatic heterocyclic compound.
[0273] <<Nitrogen-containing aromatic heterocyclic compounds>>
[0274] The number of ring members in the nitrogen-containing aromatic heterocyclic compound (when the ring structure is condensed with other ring structures as described below, the number of ring members of a single ring containing a nitrogen atom as a ring member) is preferably 5 to 10, more preferably 5 or 6, and even more preferably 5.
[0275] The number of nitrogen atoms contained in the nitrogen-containing aromatic heterocyclic compound is preferably 1 to 3, more preferably 2 or 3, and even more preferably 2.
[0276] The nitrogen-containing aromatic heterocyclic compound may be a structure in which a nitrogen-containing aromatic heterocyclic structure and another ring structure are condensed. The other ring structure is preferably an aromatic ring, more preferably an aromatic hydrocarbon ring, and still more preferably a benzene ring.
[0277] Examples of the nitrogen-containing heteroaromatic ring compound include substituted or unsubstituted imidazole compounds, substituted or unsubstituted pyrazole compounds, and substituted or unsubstituted benzopyrazole compounds.
[0278] Examples of the substituent in the imidazole compound, the pyrazole compound or the benzopyrazole compound include the substituents corresponding to R in the formula (1-1). 1 ~R 3 The substituents in the same group.
[0279] <<Nitrogen-containing aliphatic heterocyclic compounds>>
[0280] The number of ring members in the nitrogen-containing aliphatic heterocyclic compound (when the ring structure is condensed with other ring structures as described below, the number of ring members of a single ring containing a nitrogen atom as a ring member) is preferably 5 to 10, more preferably 5 or 6, and even more preferably 5.
[0281] The number of nitrogen atoms contained in the nitrogen-containing aliphatic heterocyclic compound is preferably 1 to 3, more preferably 2 or 3, and even more preferably 2.
[0282] The nitrogen-containing aliphatic heterocyclic compound may be a structure in which a nitrogen-containing aliphatic heterocyclic structure and other ring structures are condensed. As the other ring structure, an aliphatic ring structure is preferred, and an aliphatic hydrocarbon ring structure may also be used, but an aliphatic heterocyclic structure containing a nitrogen atom as a heteroatom is preferred. Furthermore, the aliphatic ring structure may be a saturated aliphatic ring structure or an unsaturated aliphatic ring structure.
[0283] Examples of the nitrogen-containing aliphatic aromatic ring compound include 1,3,4,6,7,8-hexahydro-1-methyl-2H-pyrimido[1,2-a]pyrimidine and the like.
[0284] The specific compound is also preferably a monoamine compound or a weak acid salt thereof.
[0285] In the present specification, the monoamine compound refers to a compound having only one substituted or unsubstituted amine group in its structure.
[0286] Among these, the specific compound is preferably at least one compound selected from the group consisting of aliphatic secondary amines, aliphatic tertiary amines, aromatic secondary amines, and aromatic tertiary amines, or a weak acid salt thereof, and is preferably a monoamine compound or a weak acid salt thereof.
[0287] 〔Molecular weight〕
[0288] The molecular weight of the specific compound is preferably 60 to 200 from the viewpoint of the film strength of the cured film and the insulation properties of the obtained cured film.
[0289] It is considered that when the molecular weight is 200 or less, for example, the specific compound can be easily transferred during heating, and the effect of promoting the cyclization of the polymer precursor containing a heterocyclic ring can be easily obtained.
[0290] Furthermore, it is considered that when the molecular weight is 200 or less, the specific compound is easily volatilized when heated, for example, and the amount of the specific compound remaining in the obtained cured film is reduced, so that the film strength of the cured film is easily improved.
[0291] The lower limit of the molecular weight is preferably 80 or more. The upper limit of the molecular weight is preferably 190 or less, and more preferably 180 or less.
[0292] [Specific example]
[0293] Specific examples of the specific compound include N,N-dimethylcyclohexylamine, triethylamine, 2-(dimethylamino)ethyl methacrylate, dicyclohexylamine, 4-dimethylaminopyridine, diisopropylamine, 1,3,4,6,7,8-hexahydro-1-methyl-2H-pyrimido[1,2-a]pyrimidine, imidazole, 1,2-benzopyrazole, 5-methylpyrazole-3-carboxylic acid methyl ester, N,N-dimethylaminopyridine, dibenzylamine, N-tert-butylbenzylamine, N-isopropylaniline, 4-morpholinylpyridine, etc., but are not limited to these.
[0294] 〔content〕
[0295] From the viewpoints of improving the storage stability of the composition and the elongation at break of the obtained cured film, the content of the specific compound is preferably 0.05 to 20% by mass relative to the total solid content of the curable resin composition. The lower limit is more preferably 0.1% by mass or more, further preferably 0.2% by mass or more, and particularly preferably 0.3% by mass or more. From the viewpoints of the corrosion resistance of metals (for example, copper for wiring, etc.), the upper limit is more preferably 10% by mass or less, further preferably 5% by mass or less, and particularly preferably 1% by mass or less.
[0296] Furthermore, from the viewpoints of improving the storage stability of the composition and the elongation at break of the obtained cured film, the content of the specific compound is preferably 0.5 parts by mass or more, more preferably 1 part by mass or more, and further preferably 2 parts by mass or more relative to 100 parts by mass of the polymer precursor containing the heterocycle. From the viewpoints of the corrosion resistance of metals (e.g., copper for wiring, etc.), the upper limit is, for example, preferably 20 parts by mass or less, more preferably 15 parts by mass or less, and further preferably 10 parts by mass or less.
[0297] The specific compound can be used alone or in combination of two or more. When two or more are used, the total amount is preferably within the above range.
[0298] <Polymerization initiator>
[0299] The curable resin composition of the present invention contains a polymerization initiator.
[0300] The polymerization initiator may be a photopolymerization initiator or a thermal polymerization initiator, but preferably contains a photopolymerization initiator.
[0301] 〔Photopolymerization initiator〕
[0302] The curable resin composition of the present invention preferably contains a photopolymerization initiator.
[0303] The photopolymerization initiator may also be a photocationic polymerization initiator, but is preferably a photoradical polymerization initiator. The photoradical polymerization initiator is not particularly limited and can be appropriately selected from known photoradical polymerization initiators. For example, a photoradical polymerization initiator having photosensitivity to light in the ultraviolet region to the visible region is preferred. In addition, an activator that generates active free radicals by reacting with a photoexcited sensitizer may also be used.
[0304] The photo-radical polymerization initiator preferably contains at least one photopolymerization initiator having a wavelength of at least about 50 L·mol in the range of about 300 to 800 nm (preferably 330 to 500 nm). -1 cm -1 The molar absorption coefficient of the compound can be measured using a known method. For example, it is preferably measured by an ultraviolet visible spectrophotometer (Cary-5 spectrophotometer manufactured by Varian) using an ethyl acetate solvent at a concentration of 0.01 g / L.
[0305] As a photo-radical polymerization initiator, known compounds can be used arbitrarily. For example, halogenated hydrocarbon derivatives (for example, compounds with triazine skeletons, compounds with oxadiazole skeletons, compounds with trihalomethyl groups, etc.), acylphosphine compounds such as acylphosphine oxides, hexaarylbimidazoles, oxime compounds such as oxime derivatives, organic peroxides, sulfur compounds, ketone compounds, aromatic onium salts, ketoxime ethers, aminoacetophenone compounds, hydroxyacetophenones, azo compounds, azides, metallocene compounds, organic boron compounds, iron aromatic complexes, etc. can be cited. For details of these, it is possible to refer to paragraphs 0165 to 0182 of Japanese Patent Publication No. 2016-027357 and paragraphs 0138 to 0151 of International Publication No. 2015 / 199219, and the content is incorporated into this specification.
[0306] Examples of the ketone compound include compounds described in paragraph 0087 of JP-A-2015-087611, the contents of which are incorporated herein. Among commercially available products, KAYACURE DETX (manufactured by Nippon Kayaku Co., Ltd.) can also be preferably used.
[0307] As the photoradical polymerization initiator, hydroxyacetophenone compounds, aminoacetophenone compounds and acylphosphine compounds can also be preferably used. More specifically, for example, aminoacetophenone-based initiators described in Japanese Patent Application Laid-Open No. 10-291969 and acylphosphine oxide-based initiators described in Japanese Patent No. 4225898 can also be used.
[0308] As the hydroxyacetophenone-based initiator, IRGACURE 184 (IRGACURE is a registered trademark), DAROCUR 1173, IRGACURE 500, IRGACURE 2959, and IRGACURE 127 (trade names: all manufactured by BASF Corporation) can be used.
[0309] As the aminoacetophenone-based initiator, commercially available products such as IRGACURE 907, IRGACURE 369, and IRGACURE 379 (trade names: all manufactured by BASF), and Omnirad 907, Omnirad 369, and Omnirad 379 (all manufactured by IGM Resins) can be used.
[0310] As the aminoacetophenone-based initiator, a compound described in Japanese Patent Application Laid-Open No. 2009-191179, which has an absorption maximum wavelength that matches a light source having a wavelength of 365 nm or 405 nm, can also be used.
[0311] Examples of the acylphosphine initiator include 2,4,6-trimethylbenzoyl-diphenyl-phosphine oxide, etc. Commercially available products such as IRGACURE 819 or IRGACURE TPO (trade names: both manufactured by BASF), and Omnirad 819 or Omnirad TPO (both manufactured by IGM Resins) can also be used.
[0312] Examples of the metallocene compound include IRGACURE 784 (manufactured by BASF Corporation) and the like.
[0313] As the photoradical polymerization initiator, an oxime compound can be more preferably used. By using an oxime compound, the exposure latitude can be more effectively improved. Oxime compounds are particularly preferred because they have a wide exposure latitude (exposure margin) and also function as a photocuring accelerator.
[0314] Specific examples of the oxime compound include compounds described in JP-A-2001-233842, compounds described in JP-A-2000-080068, and compounds described in JP-A-2006-342166.
[0315] Preferred oxime compounds include, for example, compounds of the following structures or 3-benzoyloxyiminobutane-2-one, 3-acetoxyiminobutane-2-one, 3-propionyloxyiminobutane-2-one, 2-acetoxyiminopentane-3-one, 2-acetoxyimino-1-phenylpropane-1-one, 2-benzoyloxyimino-1-phenylpropane-1-one, 3-(4-toluenesulfonyloxy)iminobutane-2-one, and 2-ethoxycarbonyloxyimino-1-phenylpropane-1-one. In the curable resin composition of the present invention, it is preferred to use an oxime compound (oxime-based photopolymerization initiator) as a photoradical polymerization initiator. The oxime-based photopolymerization initiator has a linking group represented by >C=NOC(=O)- in the molecule.
[0316] [Chemical formula 19]
[0317]
[0318] Among the commercially available products, IRGACURE OXE 01, IRGACURE OXE 02, IRGACURE OXE 03, IRGACURE OXE 04 (all manufactured by BASF), Adeka Optomer N-1919 (manufactured by ADEKA CORPORATION, photoradical polymerization initiator 2 described in JP-A-2012-014052) can also be preferably used. In addition, TR-PBG-304 (manufactured by Changzhou Tronly New Electronic Materials CO., LTD.), ADEKA ARKLS NCI-831 and ADEKA ARKLS NCI-930 (manufactured by ADEKA CORPORATION) can also be used. In addition, DFI-091 (manufactured by Daito Chemix Corporation) can be used.
[0319] Oxime compounds of the following structures can also be used.
[0320] [Chemical formula 20]
[0321]
[0322] In addition, oxime compounds having fluorine atoms can also be used. Specific examples of such oxime compounds include compounds described in JP-A-2010-262028, compounds 24, 36 to 40 described in paragraph 0345 of JP-A-2014-500852, and compound (C-3) described in paragraph 0101 of JP-A-2013-164471.
[0323] As the most preferred oxime compound, there can be mentioned an oxime compound having a specific substituent as disclosed in JP-A-2007-269779 or an oxime compound having a thioaryl group as disclosed in JP-A-2009-191061.
[0324] From the viewpoint of exposure sensitivity, the photoradical polymerization initiator is preferably a compound selected from the group consisting of trihalomethyltriazine compounds, benzyl dimethyl ketal compounds, α-hydroxyketone compounds, α-aminoketone compounds, acylphosphine compounds, phosphine oxide compounds, metallocene compounds, oxime compounds, triarylimidazole dimers, onium salt compounds, benzothiazole compounds, benzophenone compounds, acetophenone compounds and derivatives thereof, cyclopentadiene-benzene-iron complexes and salts thereof, halomethyloxadiazole compounds, and 3-aryl substituted coumarin compounds.
[0325] Further preferred photoradical polymerization initiators are trihalomethyl triazine compounds, α-amino ketone compounds, acyl phosphine compounds, phosphine oxide compounds, metallocene compounds, oxime compounds, triaryl imidazole dimers, onium salt compounds, benzophenone compounds, and acetophenone compounds. Further preferred are at least one compound selected from the group consisting of trihalomethyl triazine compounds, α-amino ketone compounds, oxime compounds, triaryl imidazole dimers, and benzophenone compounds. Further preferred are metallocene compounds or oxime compounds, and further preferred are oxime compounds.
[0326] In addition, the photoradical polymerization initiator may also include benzophenone, N,N'-tetraalkyl-4,4'-diaminobenzophenone (Michelle's ketone) and the like, aromatic ketones such as 2-benzyl-2-dimethylamino-1-(4-morpholinylphenyl)-butanone-1,2-methyl-1-[4-(methylthio)phenyl]-2-morpholinyl-propanone-1, quinones having condensed aromatic rings such as alkyl anthraquinone, benzoin ether compounds such as benzoin alkyl ether, benzoin and benzoin compounds such as alkyl benzoin, benzyl derivatives such as benzyl dimethyl ketal, etc. In addition, compounds represented by the following formula (I) may also be used.
[0327] [Chemical formula 21]
[0328]
[0329] In formula (I), R I00 is an alkyl group having 1 to 20 carbon atoms, an alkyl group having 2 to 20 carbon atoms interrupted by one or more oxygen atoms, an alkoxy group having 1 to 12 carbon atoms, a phenyl group, or an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, a halogen atom, a cyclopentyl group, a cyclohexyl group, an alkenyl group having 2 to 12 carbon atoms, an alkyl group having 2 to 18 carbon atoms interrupted by one or more oxygen atoms, and a phenyl or biphenyl group substituted with at least one of an alkyl group having 1 to 4 carbon atoms, R I01 is a group represented by formula (II) or is I00 The same group, R I02 ~R I04 Each is independently an alkyl group having 1 to 12 carbon atoms, an alkoxy group having 1 to 12 carbon atoms, or a halogen atom.
[0330] [Chemical formula 22]
[0331]
[0332] In the formula, R I05 ~R I07 R of the above formula (I) I02 ~R I04 same.
[0333] Furthermore, as the photoradical polymerization initiator, the compounds described in paragraphs 0048 to 0055 of International Publication No. 2015 / 125469 can also be used.
[0334] When a photopolymerization initiator is contained, the content thereof is preferably 0.1 to 30% by mass, more preferably 0.1 to 20% by mass, further preferably 0.5 to 15% by mass, and further preferably 1.0 to 10% by mass, based on the total solid content of the curable resin composition of the present invention.
[0335] The photopolymerization initiator may be contained in one kind or in two or more kinds. When two or more kinds of photopolymerization initiators are contained, it is preferable that the total amount thereof is within the above range.
[0336] 〔Thermal polymerization initiator〕
[0337] In the curable resin composition of the present invention, as a polymerization initiator, a thermal polymerization initiator may be included, and in particular, a thermal free radical polymerization initiator may be included. A thermal free radical polymerization initiator is a compound that generates free radicals by thermal energy to initiate or promote a polymerization reaction based on a polymerizable compound. By adding a thermal free radical polymerization initiator, the polymerization reaction of the polymer precursor containing a heterocycle can also be carried out together with the cyclization of the polymer precursor containing a heterocycle, so that a higher degree of heat resistance can be achieved.
[0338] Specific examples of the thermal radical polymerization initiator include compounds described in paragraphs 0074 to 0118 of JP-A-2008-063554.
[0339] When a thermal free radical polymerization initiator is included, its content is preferably 0.1 to 30% by mass, more preferably 0.1 to 20% by mass, and further preferably 5 to 15% by mass relative to the total solid content of the curable resin composition of the present invention. The thermal free radical polymerization initiator may contain only one or more than one. When two or more thermal free radical polymerization initiators are contained, the total is preferably within the above range.
[0340] <Solvent>
[0341] The curable resin composition of the present invention contains a solvent. Any known solvent can be used as the solvent. The solvent is preferably an organic solvent. Examples of the organic solvent include compounds such as esters, ethers, ketones, cyclic hydrocarbons, sulfoxides, amides, and alcohols.
[0342] In the curable resin composition of the present invention, the water content is preferably 5% by mass or less based on the total mass of the solvent from the viewpoint of suppressing coating defects during coating and improving storage stability.
[0343] The water content is preferably 3% by mass or less, more preferably 1% by mass or less, and even more preferably 0.1% by mass or less.
[0344] Furthermore, the water content may be 0% by mass.
[0345] Examples of the esters include ethyl acetate, n-butyl acetate, isobutyl acetate, hexyl acetate, amyl formate, isoamyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyl alkoxyacetates (e.g., methyl alkoxyacetate, ethyl alkoxyacetate, butyl alkoxyacetate (e.g., methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, etc.)), alkyl 3-alkoxypropionates (e.g., methyl 3-alkoxypropionate, ethyl 3-alkoxypropionate, etc. (e.g., methyl 3-methoxypropionate, ethyl 3-methoxypropionate, methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, etc.) Esters such as esters)), alkyl 2-alkoxypropionates (for example, methyl 2-alkoxypropionate, ethyl 2-alkoxypropionate, propyl 2-alkoxypropionate, etc. (for example, methyl 2-methoxypropionate, ethyl 2-methoxypropionate, propyl 2-methoxypropionate, methyl 2-ethoxypropionate, ethyl 2-ethoxypropionate)), methyl 2-alkoxy-2-methylpropionate and ethyl 2-alkoxy-2-methylpropionate (for example, methyl 2-methoxy-2-methylpropionate, ethyl 2-ethoxy-2-methylpropionate, etc.), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, methyl 2-oxobutyrate, ethyl 2-oxobutyrate, ethyl hexanoate, ethyl heptanoate, dimethyl malonate, diethyl malonate, etc. are preferred esters.
[0346] As the ethers, for example, diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl celulose acetate, ethyl celulose acetate, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, ethylene glycol monobutyl ether, ethylene glycol monobutyl ether acetate, diethylene glycol ethyl methyl ether propylene glycol monopropyl ether acetate and the like can be cited as preferred ethers.
[0347] Examples of the ketones preferably include methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, 3-methylcyclohexanone, levoglucosone, and dihydrolevoglucosone.
[0348] Examples of the cyclic hydrocarbons preferably include aromatic hydrocarbons such as toluene, xylene, and anisole, and cyclic terpenes such as limonene.
[0349] As the sulfoxides, for example, dimethyl sulfoxide can be mentioned as a preferred sulfoxide.
[0350] Preferred amides include N-methyl-2-pyrrolidone, N-ethyl-2-pyrrolidone, N,N-dimethylacetamide, N,N-dimethylformamide, N,N-dimethylisobutyramide, 3-methoxy-N,N-dimethylpropionamide, and 3-butoxy-N,N-dimethylpropionamide.
[0351] Examples of the alcohol include methanol, ethanol, 1-propanol, 2-propanol, 1-butanol, 1-pentanol, 1-hexanol, benzyl alcohol, ethylene glycol monomethyl ether, 1-methoxy-2-propanol, 2-ethoxyethanol, diethylene glycol monoethyl ether, diethylene glycol monohexyl ether, triethylene glycol monomethyl ether, propylene glycol monoethyl ether, propylene glycol monomethyl ether, polyethylene glycol monomethyl ether, polypropylene glycol, tetraethylene glycol, ethylene glycol monobutyl ether, ethylene glycol monobenzyl ether, ethylene glycol monophenyl ether, methyl phenylcarbinol, n-pentanol, methylpentanol and diacetone alcohol.
[0352] From the viewpoint of improving the properties of the coating surface, etc., a mode in which two or more solvents are mixed is also preferred.
[0353] In the present invention, preferably, it is a solvent selected from methyl 3-ethoxypropionate, ethyl 3-ethoxypropionate, ethyl celulose acetate, ethyl lactate, diethylene glycol dimethyl ether, butyl acetate, methyl 3-methoxypropionate, 2-heptanone, cyclohexanone, cyclopentanone, γ-butyrolactone, dimethyl sulfoxide, ethyl carbitol acetate, butyl carbitol acetate, N-methyl-2-pyrrolidone, propylene glycol methyl ether and propylene glycol methyl ether acetate, or a mixed solvent consisting of two or more thereof. It is particularly preferred to use dimethyl sulfoxide and γ-butyrolactone simultaneously.
[0354] From the viewpoint of coating properties, the content of the solvent is preferably an amount in which the total solid content concentration of the curable resin composition of the present invention is 5 to 80% by mass, more preferably an amount in which the total solid content concentration of the curable resin composition of the present invention is 5 to 75% by mass, further preferably an amount in which the total solid content concentration of the curable resin composition of the present invention is 10 to 70% by mass, further preferably an amount in which the total solid content concentration of the curable resin composition of the present invention is 20 to 70% by mass, and further preferably an amount in which the total solid content concentration of the curable resin composition of the present invention is 40 to 70% by mass. The solvent content can be adjusted according to the desired thickness and coating method.
[0355] The solvent may be contained in one kind or in two or more kinds. When two or more kinds of solvents are contained, it is preferred that the total amount thereof is within the above range.
[0356] <Onium salt>
[0357] The curable resin composition of the present invention may further contain an onium salt.
[0358] The type of the onium salt is not particularly limited, but preferred examples include ammonium salts, iminium salts, sulfonium salts, iodonium salts, and phosphonium salts.
[0359] Among these, ammonium salts or iminium salts are preferred from the viewpoint of high thermal stability, and sulfonium salts, iodonium salts or phosphonium salts are preferred from the viewpoint of compatibility with the polymer.
[0360] Furthermore, the onium salt is a salt of a cation having an onium structure and an anion, and the cation and the anion may or may not be bonded via a covalent bond.
[0361] That is, the onium salt may be an intramolecular salt having a cation part and an anion part in the same molecular structure, or an intermolecular salt formed by ionic bonding of cation molecules and anion molecules of different molecules, but is preferably an intermolecular salt. Furthermore, in the curable resin composition of the present invention, the cation part or cation molecule and the anion part or anion molecule may be bonded by ionic bonding or may be dissociated.
[0362] The cation in the onium salt is preferably an ammonium cation, a pyridinium cation, a sulfonium cation, an iodonium cation or a phosphonium cation, and more preferably at least one cation selected from the group consisting of a tetraalkylammonium cation, a sulfonium cation and an iodonium cation.
[0363] The onium salt used in the present invention may be a thermal base generator described later.
[0364] The thermal base generator is a compound that generates a base when heated, and examples thereof include compounds that generate a base when heated to 40° C. or higher.
[0365] 〔Ammonium salt〕
[0366] In the present invention, the ammonium salt refers to a salt of an ammonium cation and an anion.
[0367] -Ammonium cation-
[0368] As the ammonium cation, a quaternary ammonium cation is preferred.
[0369] Furthermore, the ammonium cation is preferably a cation represented by the following formula (101).
[0370] [Chemical formula 23]
[0371]
[0372] In formula (101), R 1 ~R 4Each independently represents a hydrogen atom or a hydrocarbon group, R 1 ~R 4 At least two of them may be bonded to form a ring.
[0373] In formula (101), R 1 ~R 4 Each of R is independently preferably a hydrocarbon group, more preferably an alkyl group or an aryl group, and still more preferably an alkyl group having 1 to 10 carbon atoms or an aryl group having 6 to 12 carbon atoms. 1 ~R 4 It may have a substituent, and examples of the substituent include a hydroxyl group, an aryl group, an alkoxy group, an aryloxy group, an arylcarbonyl group, an alkylcarbonyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, and an acyloxy group.
[0374] When R 1 ~R 4 When at least two of the above are bonded to form a ring, the above ring may contain a hetero atom. Examples of the above hetero atom include a nitrogen atom.
[0375] The ammonium cation is preferably represented by any one of the following formulas (Y1-1) and (Y1-2).
[0376] [Chemical formula 24]
[0377]
[0378] In formula (Y1-1) and (Y1-2), R 101 represents an n-valent organic group, R 1 The meaning of is the same as R in formula (101) 1 Same, Ar 101 and Ar 102 Each independently represents an aryl group, and n represents an integer of 1 or greater.
[0379] In formula (Y1-1), R 101 It is preferably a group formed by removing n hydrogen atoms from an aliphatic hydrocarbon, an aromatic hydrocarbon, or a structure formed by bonding these hydrocarbons, and more preferably a group formed by removing n hydrogen atoms from a saturated aliphatic hydrocarbon having 2 to 30 carbon atoms, benzene, or naphthalene.
[0380] In formula (Y1-1), n is preferably 1 to 4, more preferably 1 or 2, and further preferably 1.
[0381] In formula (Y1-2), Ar 101 and Ar 102 Each independently is preferably a phenyl group or a naphthyl group, and more preferably a phenyl group.
[0382] -Anions-
[0383] The anion in the ammonium salt is preferably one selected from carboxylic acid anions, phenolic anions, phosphate anions and sulfate anions, and is more preferably a carboxylic acid anion for the sake of both salt stability and thermal decomposition. That is, the ammonium salt is more preferably a salt of an ammonium cation and a carboxylic acid anion.
[0384] The carboxylate anion is preferably an anion of a divalent or higher carboxylic acid having two or more carboxyl groups, and more preferably an anion of a divalent carboxylic acid. According to this embodiment, the stability, curability and developability of the curable resin composition can be further improved. In particular, by using an anion of a divalent carboxylic acid, the stability, curability and developability of the curable resin composition can be further improved.
[0385] The carboxylate anion is preferably represented by the following formula (X1).
[0386] [Chemical formula 25]
[0387]
[0388] In formula (X1), EWG represents an electron withdrawing group.
[0389] In this embodiment, the electron withdrawing group refers to a substituent constant σm of Hammett showing a positive value. Here, σm is described in detail in General Comments of Yufu Mitsuno, Journal of the Society of Synthetic Organic Chemistry, Vol. 23, No. 8 (1965) p. 631-642. In addition, the electron withdrawing group in this embodiment is not limited to the substituent described in the above literature.
[0390] As an example of a substituent showing a positive σm value, CF 3 Basis (σm=0.43), CF 3 C(=O) group (σm=0.63), HC≡C group (σm=0.21), CH 2 =CH group (σm = 0.06), Ac group (σm = 0.38), MeOC (=O) group (σm = 0.37), MeC (=O) CH = CH group (σm = 0.21), PhC (=O) group (σm = 0.34), H 2 NC(=O)CH 2 In addition, Me represents a methyl group, Ac represents an acetyl group, and Ph represents a phenyl group (the same applies hereinafter).
[0391] EWG is preferably a group represented by the following formulae (EWG-1) to (EWG-6).
[0392] [Chemical formula 26]
[0393]
[0394] In formulas (EWG-1) to (EWG-6), R x1 ~R x3 Each independently represents a hydrogen atom, an alkyl group, an alkenyl group, an aryl group, a hydroxyl group or a carboxyl group, and Ar represents an aromatic group.
[0395] In the present invention, the carboxylate anion is preferably represented by the following formula (XA).
[0396] [Chemical formula 27]
[0397]
[0398] In formula (XA), L 10 represents a single bond or is selected from alkylene, alkenylene, aromatic group, -NR X - and the divalent linking group in the group consisting of these combinations, R X represents a hydrogen atom, an alkyl group, an alkenyl group or an aryl group.
[0399] Specific examples of the carboxylic acid anion include a maleic acid anion, a phthalic acid anion, an N-phenyliminodiacetic acid anion, and an oxalic acid anion.
[0400] From the viewpoint of facilitating the cyclization of the polymer precursor containing a heterocyclic ring at low temperature and facilitating improving the storage stability of the curable resin composition, the onium salt in the present invention contains an ammonium cation as a cation, and preferably the onium salt contains an anion having a pKa (pKaH) of a conjugate acid of 2.5 or less as an anion, and more preferably contains an anion having a pKa (pKaH) of 1.8 or less.
[0401] The lower limit of the pKa is not particularly limited, but is preferably -3 or more, more preferably -2 or more, from the viewpoint that the generated base is less likely to be neutralized and the cyclization efficiency of the heterocyclic ring-containing polymer precursor or the like is improved.
[0402] As the above-mentioned pKa, the values described in Determination of Organic Structures by Physical Methods (Author: Brown, HC, McDaniel, DH, Hafliger, O., Nachod, FC; Editor: Braude, EA, Nachod, FC; Academic Press, New York, 1955) or Data for Biochemical Research (Author: Dawson, RMC et al; Oxford, Clarendon Press, 1959) can be referred to. For compounds not described in these documents, the values calculated from the structural formula using ACD / pKa (manufactured by ACD / Labs) software are used.
[0403] Specific examples of the ammonium salt include the following compounds, but the present invention is not limited to these.
[0404] [Chemical formula 28]
[0405]
[0406] 〔Iminium salt〕
[0407] In the present invention, the iminium salt refers to a salt of an iminium cation and an anion. Examples of the anion include the same anions as those in the above-mentioned ammonium salt, and the preferred embodiments are also the same.
[0408] -Iminium cation-
[0409] As the iminium cation, a pyridinium cation is preferred.
[0410] Furthermore, as the iminium cation, a cation represented by the following formula (102) is also preferred.
[0411] [Chemical formula 29]
[0412]
[0413] In formula (102), R 5 and R 6 Each independently represents a hydrogen atom or a hydrocarbon group, R 7 Represents a hydrocarbon group, R 5 ~R 7 At least two of them may be bonded to form a ring.
[0414] In formula (102), R 5 and R 6 The meaning of is the same as R in the above formula (101) 1~R 4 Same, the preferred method is also the same.
[0415] In formula (102), preferably R 7 With R 5 and R 6 At least one of them is bonded to form a ring. The above ring may contain a heteroatom. As the above heteroatom, a nitrogen atom can be mentioned. And, as the above ring, a pyridine ring is preferred.
[0416] The iminium cation is preferably represented by any one of the following formulas (Y1-3) to (Y1-5).
[0417] [Chemical formula 30]
[0418]
[0419] In formulas (Y1-3) to (Y1-5), R 101 represents an n-valent organic group, R 5 The meaning of is the same as R in formula (102) 5 Same, R 7 The meaning of is the same as R in formula (102) 7 Similarly, n and m represent an integer greater than or equal to 1.
[0420] In formula (Y1-3), R 101 It is preferably a group formed by removing n hydrogen atoms from an aliphatic hydrocarbon, an aromatic hydrocarbon, or a structure formed by bonding these hydrocarbons, and more preferably a group formed by removing n hydrogen atoms from a saturated aliphatic hydrocarbon having 2 to 30 carbon atoms, benzene, or naphthalene.
[0421] In formula (Y1-3), n is preferably 1 to 4, more preferably 1 or 2, and further preferably 1.
[0422] In the formula (Y1-5), m is preferably 0 to 4, more preferably 1 or 2, and even more preferably 1.
[0423] Specific examples of the iminium salt include the following compounds, but the present invention is not limited to these.
[0424] [Chemical formula 31]
[0425]
[0426] 〔Sulfonium salt〕
[0427] In the present invention, the sulfonium salt refers to a salt of a sulfonium cation and an anion. Examples of the anion include the same anions as those in the above-mentioned ammonium salt, and preferred embodiments are also the same.
[0428] -Sulfonium cation-
[0429] The sulfonium cation is preferably a tertiary sulfonium cation, and more preferably a triarylsulfonium cation.
[0430] Furthermore, the sulfonium cation is preferably a cation represented by the following formula (103).
[0431] [Chemical formula 32]
[0432]
[0433] In formula (103), R 8 ~R 10 Each independently represents a hydrocarbon group.
[0434] R 8 ~R 10 Each independently is preferably an alkyl group or an aryl group, more preferably an alkyl group having 1 to 10 carbon atoms or an aryl group having 6 to 12 carbon atoms, further preferably an aryl group having 6 to 12 carbon atoms, and further preferably a phenyl group.
[0435] R 8 ~R 10 It may have a substituent, and examples of the substituent include a hydroxyl group, an aryl group, an alkoxy group, an aryloxy group, an arylcarbonyl group, an alkylcarbonyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, an acyloxy group, etc. Among these, as a substituent, it is preferred to have an alkyl group or an alkoxy group, more preferably a branched alkyl group or an alkoxy group, and even more preferably a branched alkyl group having 3 to 10 carbon atoms or an alkoxy group having 1 to 10 carbon atoms.
[0436] R 8 ~R 10 The groups may be the same or different, but are preferably the same from the viewpoint of synthetic suitability.
[0437] Specific examples of the sulfonium salt include the following compounds, but the present invention is not limited to these.
[0438] [Chemical formula 33]
[0439]
[0440] 〔Iodized salt〕
[0441] In the present invention, the iodine salt refers to a salt of an iodine cation and an anion. Examples of the anion include the same anions as those in the above-mentioned ammonium salt, and the preferred embodiments are also the same.
[0442] -Iodide cation-
[0443] As the iodonium cation, a diaryliodonium cation is preferred.
[0444] Furthermore, the iodine cation is preferably a cation represented by the following formula (104).
[0445] [Chemical formula 34]
[0446]
[0447] In formula (104), R 11 and R 12 Each independently represents a hydrocarbon group.
[0448] R 11 and R 12 Each independently is preferably an alkyl group or an aryl group, more preferably an alkyl group having 1 to 10 carbon atoms or an aryl group having 6 to 12 carbon atoms, further preferably an aryl group having 6 to 12 carbon atoms, and further preferably a phenyl group.
[0449] R 11 and R 12 It may have a substituent, and examples of the substituent include a hydroxyl group, an aryl group, an alkoxy group, an aryloxy group, an arylcarbonyl group, an alkylcarbonyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, an acyloxy group, etc. Among these, as a substituent, it is preferred to have an alkyl group or an alkoxy group, more preferably a branched alkyl group or an alkoxy group, and even more preferably a branched alkyl group having 3 to 10 carbon atoms or an alkoxy group having 1 to 10 carbon atoms.
[0450] R 11 and R 12 The groups may be the same or different, but are preferably the same from the viewpoint of synthetic suitability.
[0451] Specific examples of the iodine salt include the following compounds, but the present invention is not limited thereto.
[0452] [Chemical formula 35]
[0453]
[0454] 〔Phosphonium salt〕
[0455] In the present invention, the phosphonium salt refers to a salt of a phosphonium cation and an anion. Examples of the anion include the same anions as those in the above-mentioned ammonium salt, and preferred embodiments are also the same.
[0456] -Phosphonium cation-
[0457] The phosphonium cation is preferably a quaternary phosphonium cation, and examples thereof include a tetraalkylphosphonium cation and a triarylmonoalkylphosphonium cation.
[0458] Furthermore, the phosphonium cation is preferably a cation represented by the following formula (105).
[0459] [Chemical formula 36]
[0460]
[0461] In formula (105), R 13 ~R 16 Each independently represents a hydrogen atom or a hydrocarbon group.
[0462] R 13 ~R 16 Each independently is preferably an alkyl group or an aryl group, more preferably an alkyl group having 1 to 10 carbon atoms or an aryl group having 6 to 12 carbon atoms, further preferably an aryl group having 6 to 12 carbon atoms, and further preferably a phenyl group.
[0463] R 13 ~R 16 It may have a substituent, and examples of the substituent include a hydroxyl group, an aryl group, an alkoxy group, an aryloxy group, an arylcarbonyl group, an alkylcarbonyl group, an alkoxycarbonyl group, an aryloxycarbonyl group, an acyloxy group, etc. Among these, as a substituent, it is preferred to have an alkyl group or an alkoxy group, more preferably a branched alkyl group or an alkoxy group, and even more preferably a branched alkyl group having 3 to 10 carbon atoms or an alkoxy group having 1 to 10 carbon atoms.
[0464] R 13 ~R 16 The groups may be the same or different, but are preferably the same from the viewpoint of synthetic suitability.
[0465] Specific examples of the phosphonium salt include the following compounds, but the present invention is not limited to these.
[0466] [Chemical formula 37]
[0467]
[0468] When the curable resin composition of the present invention includes an onium salt, the content of the onium salt is preferably 0.1 to 50% by mass relative to the total solid content of the curable resin composition of the present invention. The lower limit is more preferably 0.5% by mass or more, more preferably 0.85% by mass or more, and more preferably 1% by mass or more. The upper limit is more preferably 30% by mass or less, more preferably 20% by mass or less, more preferably 10% by mass or less, and may be 5% by mass or less, or 4% by mass or less.
[0469] The onium salt can be used alone or in combination of two or more. When two or more are used, the total amount is preferably within the above range.
[0470] <Thermal alkali generator>
[0471] The curable resin composition of the present invention may further contain a thermal base generator.
[0472] The other thermal base generator may be a compound belonging to the above-mentioned onium salt, or may be a thermal base generator other than the above-mentioned onium salt.
[0473] Examples of the thermal base generator other than the above-mentioned onium salt include nonionic thermal base generators.
[0474] Examples of the nonionic thermal base generator include compounds represented by formula (B1) or formula (B2).
[0475] [Chemical formula 38]
[0476]
[0477] In formula (B1) and formula (B2), Rb 1 , Rb 2 and Rb 3 are independently an organic group without a tertiary amine structure, a halogen atom or a hydrogen atom. 1 and Rb 2 will not become a hydrogen atom at the same time. 1 , Rb 2 and Rb 3 In addition, in this specification, the tertiary amine structure refers to a structure in which the three bonds of the trivalent nitrogen atom are covalently bonded to the carbon atoms of the hydrocarbon system. Therefore, when the bonded carbon atom is a carbon atom constituting a carbonyl group, that is, when an amide group is formed together with the nitrogen atom, it is not limited to this.
[0478] In formula (B1) and (B2), regarding Rb 1 , Rb 2 and Rb 3 , preferably at least one of them contains a cyclic structure, more preferably at least two of them contain a cyclic structure. As the cyclic structure, it can be any one of a monocyclic ring and a condensed ring, preferably a monocyclic ring or a condensed ring formed by condensing two monocyclic rings. The monocyclic ring is preferably a 5-membered ring or a 6-membered ring, more preferably a 6-membered ring. The monocyclic ring is preferably a cyclohexane ring and a benzene ring, more preferably a cyclohexane ring.
[0479] More specifically, Rb 1 and Rb 2Preferably, it is a hydrogen atom, an alkyl group (preferably having 1 to 24 carbon atoms, more preferably 2 to 18, and further preferably 3 to 12), an alkenyl group (preferably having 2 to 24 carbon atoms, more preferably 2 to 18, and further preferably 3 to 12), an aryl group (preferably having 6 to 22 carbon atoms, more preferably 6 to 18, and further preferably 6 to 10) or an arylalkyl group (preferably having 7 to 25 carbon atoms, more preferably 7 to 19, and further preferably 7 to 12). These groups may have a substituent within the range in which the effects of the present invention are exerted. Rb 1 With Rb 2 They may be bonded to each other to form a ring. The formed ring is preferably a 4- to 7-membered nitrogen-containing heterocyclic ring. 1 and Rb 2 Particularly preferred is a linear, branched or cyclic alkyl group which may have a substituent (preferably having 1 to 24 carbon atoms, more preferably 2 to 18, and even more preferably 3 to 12 carbon atoms), more preferably a cycloalkyl group which may have a substituent (preferably having 3 to 24 carbon atoms, more preferably 3 to 18, and even more preferably 3 to 12 carbon atoms), and even more preferably a cyclohexyl group which may have a substituent.
[0480] As Rb 3 , examples thereof include alkyl groups (preferably having 1 to 24 carbon atoms, more preferably 2 to 18, and further preferably 3 to 12), aryl groups (preferably having 6 to 22 carbon atoms, more preferably 6 to 18, and further preferably 6 to 10), alkenyl groups (preferably having 2 to 24 carbon atoms, more preferably 2 to 12, and further preferably 2 to 6), arylalkyl groups (preferably having 7 to 23 carbon atoms, more preferably 7 to 19, and further preferably 7 to 12), arylalkenyl groups (preferably having 8 to 24 carbon atoms, more preferably 8 to 20, and further preferably 8 to 16), alkoxy groups (preferably having 1 to 24 carbon atoms, more preferably 2 to 18, and further preferably 3 to 12), aryloxy groups (preferably having 6 to 22 carbon atoms, more preferably 6 to 18, and further preferably 6 to 12), and arylalkoxy groups (preferably having 7 to 23 carbon atoms, more preferably 7 to 19, and further preferably 7 to 12). Among them, preferred are cycloalkyl groups (preferably having 3 to 24 carbon atoms, more preferably 3 to 18 carbon atoms, and even more preferably 3 to 12 carbon atoms), arylalkenyl groups, and arylalkoxy groups. 3 The compound may further have a substituent within a range where the effects of the present invention are exhibited.
[0481] The compound represented by formula (B1) is preferably a compound represented by the following formula (B1-1) or the following formula (B1-2).
[0482] [Chemical formula 39]
[0483]
[0484] In the formula, Rb 11 and Rb 12 and Rb 31 and Rb 32 Respectively with Rb in formula (B1) 1 and Rb 2 same.
[0485] R 13 is an alkyl group (preferably having 1 to 24 carbon atoms, more preferably 2 to 18, and further preferably 3 to 12), an alkenyl group (preferably having 2 to 24 carbon atoms, more preferably 2 to 18, and further preferably 3 to 12), an aryl group (preferably having 6 to 22 carbon atoms, more preferably 6 to 18, and further preferably 6 to 12), or an arylalkyl group (preferably having 7 to 23 carbon atoms, more preferably 7 to 19, and further preferably 7 to 12), and may have a substituent within the range in which the effects of the present invention are exerted. 13 Preferred is an arylalkyl group.
[0486] R 33 and Rb 34 Each of them is independently a hydrogen atom, an alkyl group (preferably having 1 to 12 carbon atoms, more preferably 1 to 8, and further preferably 1 to 3), an alkenyl group (preferably having 2 to 12 carbon atoms, more preferably 2 to 8, and further preferably 2 to 3), an aryl group (preferably having 6 to 22 carbon atoms, more preferably 6 to 18, and further preferably 6 to 10), and an arylalkyl group (preferably having 7 to 23 carbon atoms, more preferably 7 to 19, and further preferably 7 to 11), and is preferably a hydrogen atom.
[0487] R 35 It is an alkyl group (preferably having 1 to 24 carbon atoms, more preferably 1 to 12, and further preferably 3 to 8), an alkenyl group (preferably having 2 to 12 carbon atoms, more preferably 2 to 12, and further preferably 3 to 8), an aryl group (preferably having 6 to 22 carbon atoms, more preferably 6 to 18, and further preferably 6 to 12), and an arylalkyl group (preferably having 7 to 23 carbon atoms, more preferably 7 to 19, and further preferably 7 to 12), and is preferably an aryl group.
[0488] The compound represented by formula (B1-1) is preferably a compound represented by formula (B1-1a).
[0489] [Chemical formula 40]
[0490]
[0491] R 11 and Rb 12 The meaning is the same as Rb in formula (B1-1) 11 and Rb 12 same.
[0492] R 15 and Rb 16 It is a hydrogen atom, an alkyl group (preferably having 1 to 12 carbon atoms, more preferably 1 to 6, and further preferably 1 to 3), an alkenyl group (preferably having 2 to 12 carbon atoms, more preferably 2 to 6, and further preferably 2 to 3), an aryl group (preferably having 6 to 22 carbon atoms, more preferably 6 to 18, and further preferably 6 to 10), an arylalkyl group (preferably having 7 to 23 carbon atoms, more preferably 7 to 19, and further preferably 7 to 11), and is preferably a hydrogen atom or a methyl group.
[0493] R 17 It is an alkyl group (preferably having 1 to 24 carbon atoms, more preferably 1 to 12, and further preferably 3 to 8), an alkenyl group (preferably having 2 to 12 carbon atoms, more preferably 2 to 12, and further preferably 3 to 8), an aryl group (preferably having 6 to 22 carbon atoms, more preferably 6 to 18, and further preferably 6 to 12), and an arylalkyl group (preferably having 7 to 23 carbon atoms, more preferably 7 to 19, and further preferably 7 to 12), among which an aryl group is preferred.
[0494] The molecular weight of the nonionic thermal base generator is preferably 800 or less, more preferably 600 or less, and further preferably 500 or less. The lower limit is preferably 100 or more, more preferably 200 or more, and further preferably 300 or more.
[0495] As specific examples of the compound serving as a thermal base generator among the above-mentioned onium salts or specific examples of the thermal base generator other than the above-mentioned onium salts, the following compounds can be mentioned.
[0496] [Chemical formula 41]
[0497]
[0498] [Chemical formula 42]
[0499]
[0500] [Chemical formula 43]
[0501]
[0502] The content of other thermal base generating agents is preferably 0.1 to 50% by mass relative to the total solid content of the curable resin composition of the present invention. The lower limit is more preferably 0.5% by mass or more, and more preferably 1% by mass or more. The upper limit is more preferably 30% by mass or less, and more preferably 20% by mass or less. The thermal base generating agent can be used alone or in combination. When two or more are used, the total amount is preferably within the above range.
[0503] <Polymerizable compounds>
[0504] [Free radical polymerizable compound]
[0505] The curable resin composition of the present invention preferably further contains a polymerizable compound.
[0506] As the polymerizable compound, a free radical polymerizable compound can be used. The free radical polymerizable compound is a compound having a free radical polymerizable group. As the free radical polymerizable group, groups having ethylenically unsaturated bonds such as vinyl, allyl, vinylphenyl, and (meth)acryloyl can be cited. The free radical polymerizable group is preferably a (meth)acryloyl group, and from the viewpoint of reactivity, more preferably a (meth)acryloyloxy group.
[0507] The number of radical polymerizable groups possessed by the radical polymerizable compound may be 1 or 2 or more, but preferably the radical polymerizable compound has 2 or more radical polymerizable groups, more preferably 3 or more. The upper limit is preferably 15 or less, more preferably 10 or less, and further preferably 8 or less.
[0508] The molecular weight of the radical polymerizable compound is preferably 2,000 or less, more preferably 1,500 or less, and further preferably 900 or less. The lower limit of the molecular weight of the radical polymerizable compound is preferably 100 or more.
[0509] From the viewpoint of developability, the curable resin composition of the present invention preferably contains at least one free radical polymerizable compound having two or more functional groups, more preferably at least one free radical polymerizable compound having three or more functional groups. In addition, it may be a mixture of a free radical polymerizable compound having two or more functional groups and a free radical polymerizable compound having three or more functional groups. For example, the number of functional groups of a polymerizable monomer having two or more functional groups means that the number of free radical polymerizable groups in one molecule is two or more.
[0510] Specific examples of free radical polymerizable compounds include unsaturated carboxylic acids (e.g., acrylic acid, methacrylic acid, itaconic acid, crotonic acid, isocrotonic acid, maleic acid, etc.) or their esters and amides, preferably esters of unsaturated carboxylic acids and polyol compounds and amides of unsaturated carboxylic acids and polyamine compounds. In addition, addition reaction products of unsaturated carboxylic acid esters or amides having nucleophilic substituents such as hydroxyl groups, amino groups, sulfhydryl groups, etc., and monofunctional or polyfunctional isocyanates or epoxies, or dehydration condensation reaction products with monofunctional or polyfunctional carboxylic acids, etc. can also be preferably used. In addition, unsaturated carboxylates or amides with electron-withdrawing substituents such as isocyanate or epoxy groups and addition reactants of monofunctional or polyfunctional alcohols, amines, and thiols, and substitution reactants of unsaturated carboxylates or amides with leaving substituents such as halogenogroup or tosyloxy group and monofunctional or polyfunctional alcohols, amines, and thiols can also be preferably used. And, as another example, it is also possible to use a compound group replaced by vinylbenzene derivatives such as unsaturated phosphonic acid, styrene, vinyl ether, and allyl ether instead of the above-mentioned unsaturated carboxylic acid. As a specific example, it is possible to refer to the records of paragraphs 0113 to 0122 of Japanese Patent Gazette No. 2016-027357, and these contents are incorporated into this specification.
[0511] Furthermore, the radical polymerizable compound is preferably a compound having a boiling point of 100° C. or higher under normal pressure. Examples thereof include compounds obtained by adding ethylene oxide or propylene oxide to a polyfunctional alcohol such as polyethylene glycol di(meth)acrylate, trimethylolethane tri(meth)acrylate, neopentyl glycol di(meth)acrylate, pentaerythritol tri(meth)acrylate, pentaerythritol tetra(meth)acrylate, dipentaerythritol penta(meth)acrylate, dipentaerythritol hexa(meth)acrylate, hexanediol (meth)acrylate, trimethylolpropane tri(acryloxypropyl) ether, tri(acryloxyethyl) isocyanurate, glycerol or trimethylolethane, and then (meth)acrylating the resulting compound. Esterified compounds, such as urethane (meth) acrylates described in Japanese Patent Publication No. 48-041708, Japanese Patent Publication No. 50-006034, Japanese Patent Publication No. 51-037193, polyester acrylates described in Japanese Patent Publication No. 48-064183, Japanese Patent Publication No. 49-043191, Japanese Patent Publication No. 52-030490, epoxy acrylates as reaction products of epoxy resin and (meth) acrylic acid, and polyfunctional acrylates or methacrylates and mixtures thereof. Also preferred are compounds described in paragraphs 0254 to 0257 of Japanese Patent Publication No. 2008-292970. Also, polyfunctional (meth) acrylates obtained by reacting a compound having a cyclic ether group and an ethylenically unsaturated bond such as (meth) acrylate glycidyl with a polyfunctional carboxylic acid can be cited.
[0512] Furthermore, as preferred radical polymerizable compounds other than the above, compounds having a fluorene ring and having two or more ethylenically unsaturated bond-containing groups or cardo resins described in JP-A-2010-160418, JP-A-2010-129825, and JP-A-4364216 can also be used.
[0513] In addition, as other examples, specific unsaturated compounds described in Japanese Patent Publication No. 46-043946, Japanese Patent Publication No. 01-040337, Japanese Patent Publication No. 01-040336, or vinylphosphonic acid compounds described in Japanese Patent Publication No. 02-025493 can also be cited. In addition, compounds containing perfluoroalkyl groups described in Japanese Patent Publication No. 61-022048 can also be used. In addition, substances introduced as photopolymerizable monomers and oligomers in the Journal of the Japanese Adhesion Association vol. 20, No. 7, pages 300 to 308 (1984) can also be used.
[0514] In addition to the above, compounds described in paragraphs 0048 to 0051 of JP-A-2015-034964 and compounds described in paragraphs 0087 to 0131 of WO-2015 / 199219 can also be preferably used, and these contents are incorporated into the present specification.
[0515] Furthermore, compounds described in Japanese Patent Application Laid-Open No. 10-062986 as formula (1) and formula (2) together with specific examples thereof, in which ethylene oxide or propylene oxide is added to a polyfunctional alcohol and then (meth)acrylated, can also be used as radical polymerizable compounds.
[0516] In addition, the compounds described in paragraphs 0104 to 0131 of JP-A-2015-187211 can also be used as the radical polymerizable compound, and these contents are incorporated into the present specification.
[0517] As the radical polymerizable compound, dipentaerythritol triacrylate (commercially available as KAYARAD D-330; manufactured by Nippon Kayaku Co., Ltd.), dipentaerythritol tetraacrylate (commercially available as KAYARAD D-320; manufactured by Nippon Kayaku Co., Ltd., A-TMMT: manufactured by Shin-Nakamura Chemical Co., Ltd.), dipentaerythritol penta(meth)acrylate (commercially available as KAYARAD D-310; manufactured by Nippon Kayaku Co., Ltd.), dipentaerythritol hexa(meth)acrylate (commercially available as KAYARAD DPHA; manufactured by Nippon Kayaku Co., Ltd., A-DPH; manufactured by Shin-Nakamura Chemical Co., Ltd.), and structures in which (meth)acryloyl groups of these are bonded via ethylene glycol residues or propylene glycol residues. These oligomer types can also be used.
[0518] Examples of commercially available radical polymerizable compounds include SR-494, a tetrafunctional acrylate having four vinyloxy chains, manufactured by Sartomer Company, Inc.; SR-209, 231, and 239, a bifunctional methacrylate having four vinyloxy chains, manufactured by Sartomer Company, Inc.; DPCA-60, a hexafunctional acrylate having six pentyloxy chains, manufactured by Nippon Kayaku Co., Ltd.; TPA-330, a trifunctional acrylate having three isobutyleneoxy chains; urethane oligomers UAS-10 and UAB-140 (manufactured by Nippon Paper Industries Co., Ltd.); NK Ester M-40G, NK Ester 4G, NK Ester M-9300, NK Ester A-9300, UA-7200 (manufactured by Shin-Nakamura Chemical Co., Ltd.); DPHA-40H (manufactured by Nippon Kayaku Co., Ltd.); Kayaku Co., Ltd.), UA-306H, UA-306T, UA-306I, AH-600, T-600, AI-600 (manufactured by Kyoeisha Chemical Co., Ltd.), BLEMMER PME400 (manufactured by NOF CORPORATION), etc.
[0519] As the radical polymerizable compound, urethane acrylates described in JP-B-48-041708, JP-A-51-037193, JP-B-02-032293, and JP-B-02-016765, or urethane compounds having an ethylene oxide skeleton as described in JP-B-58-049860, JP-B-56-017654, JP-B-62-039417, and JP-B-62-039418 are also preferred. As the radical polymerizable compound, compounds having an amino structure or a sulfide structure in the molecule described in JP-A-63-277653, JP-A-63-260909, and JP-A-01-105238 can also be used.
[0520] The radical polymerizable compound may also be a radical polymerizable compound having an acid group such as a carboxyl group or a phosphoric acid group. The radical polymerizable compound having an acid group is preferably an ester of an aliphatic polyhydroxy compound and an unsaturated carboxylic acid, and more preferably a radical polymerizable compound having an acid group by reacting a non-aromatic carboxylic acid anhydride with an unreacted hydroxyl group of an aliphatic polyhydroxy compound. It is particularly preferred that the aliphatic polyhydroxy compound is a compound of pentaerythritol or dipentaerythritol among the radical polymerizable compounds having an acid group by reacting a non-aromatic carboxylic acid anhydride with an unreacted hydroxyl group of an aliphatic polyhydroxy compound. As commercially available products, for example, polyacid-modified acrylic oligomers manufactured by TOAGOSEI CO., LTD. include M-510, M-520, etc.
[0521] The preferred acid value of the radical polymerizable compound having an acid group is 0.1 to 40 mgKOH / g, and particularly preferably 5 to 30 mgKOH / g. If the acid value of the radical polymerizable compound is within the above range, the workability in production is excellent, and further, the developability is excellent. In addition, the polymerizability is good. The above acid value is measured according to the description of JIS K 0070:1992.
[0522] The curable resin composition of the present invention preferably uses a bifunctional methacrylate or acrylate from the viewpoint of pattern resolution and film stretchability.
[0523] As specific compounds, triethylene glycol diacrylate, triethylene glycol dimethacrylate, tetraethylene glycol dimethacrylate, tetraethylene glycol diacrylate, PEG200 diacrylate (polyethylene glycol diacrylate, and the formula weight of the polyethylene glycol chain is about 200), PEG200 dimethacrylate, PEG600 diacrylate, PEG600 dimethacrylate, polyethylene glycol diacrylate, polyethylene glycol dimethacrylate, neopentyl glycol diacrylate, neopentyl glycol dimethacrylate, 3-methyl-1,5-pentanediol diacrylate, 1,6-hexanediol diacrylate, Acrylate, 1,6-hexanediol dimethacrylate, dimethylol-tricyclodecane diacrylate, dimethylol-tricyclodecane dimethacrylate, bisphenol A EO (ethylene oxide) adduct diacrylate, bisphenol A EO adduct dimethacrylate, bisphenol A PO adduct diacrylate, bisphenol A EO adduct dimethacrylate, 2-hydroxy-3-acryloxypropyl methacrylate, isocyanuric acid EO modified diacrylate, isocyanuric acid modified dimethacrylate, and bifunctional acrylate having a urethane bond, bifunctional methacrylate having a urethane bond. These can be used in combination of two or more as needed.
[0524] Examples of the bifunctional or higher-functional radical crosslinking agent include diallyl phthalate and triallyl trimellitate.
[0525] From the viewpoint of suppressing the warping accompanying the elastic modulus control of the cured film, as a free radical polymerizable compound, a monofunctional free radical polymerizable compound can be preferably used. As a monofunctional free radical polymerizable compound, n-butyl (meth)acrylate, 2-ethylhexyl (meth)acrylate, 2-hydroxyethyl (meth)acrylate, butoxyethyl (meth)acrylate, carbitol (meth)acrylate, cyclohexyl (meth)acrylate, benzyl (meth)acrylate, phenoxyethyl (meth)acrylate, N-hydroxymethyl (meth)acrylamide, glycidyl (meth)acrylate, polyethylene glycol mono (meth)acrylate, polypropylene glycol mono (meth)acrylate and other (meth)acrylic acid derivatives, N-vinyl pyrrolidone, N-vinyl caprolactam and other N-vinyl compounds, allyl glycidyl ether and other allyl compounds can be preferably used. As a monofunctional free radical polymerizable compound, in order to suppress volatilization before exposure, it is also preferably a compound having a boiling point of 100°C or more at normal pressure.
[0526] [Polymerizable compounds other than the above-mentioned radical polymerizable compounds]
[0527] The curable resin composition of the present invention may further contain polymerizable compounds other than the above-mentioned radical polymerizable compounds. Examples of polymerizable compounds other than the above-mentioned radical polymerizable compounds include compounds having a hydroxymethyl group, an alkoxymethyl group or an acyloxymethyl group; epoxy compounds; cyclohexane compounds; and benzoxazine compounds.
[0528] -Compounds having a hydroxymethyl group, an alkoxymethyl group or an acyloxymethyl group-
[0529] As the compound having a hydroxymethyl group, an alkoxymethyl group or an acyloxymethyl group, a compound represented by the following formula (AM1), (AM4) or (AM5) is preferred.
[0530] [Chemical formula 44]
[0531]
[0532] (wherein, t represents an integer from 1 to 20, R 104 represents a t-valent organic group having 1 to 200 carbon atoms, R 105 Indicates -OR 106 or-OCO-R 107 The group represented by R 106 represents a hydrogen atom or an organic group having 1 to 10 carbon atoms, R 107 It represents an organic group having 1 to 10 carbon atoms.
[0533] [Chemical formula 45]
[0534]
[0535] (Where R 404 represents a divalent organic group having 1 to 200 carbon atoms, R 405 Indicates -OR 406 or-OCO-R 407 The group represented by R 406 represents a hydrogen atom or an organic group having 1 to 10 carbon atoms, R 407 It represents an organic group having 1 to 10 carbon atoms.
[0536] [Chemical formula 46]
[0537]
[0538] (wherein, u represents an integer from 3 to 8, R 504 represents a u-valent organic group having 1 to 200 carbon atoms, R 505 Indicates -OR 506 or-OCO-R 507 The group represented by R 506 represents a hydrogen atom or an organic group having 1 to 10 carbon atoms, R 507 It represents an organic group having 1 to 10 carbon atoms.
[0539] Specific examples of the compound represented by formula (AM4) include 46DMOC, 46DMOEP (these are trade names, manufactured by ASAHI YUKIZAI CORPORATION), DML-MBPC, DML-MBOC, DML-OCHP, DML-PCHP, DML-PC, DML-PTBP, DML-34X, DML-EP, DML-POP, dimethylolBisOC-P, DML-PFP, DML-PSBP, DML-MTrisPC (these are trade names, manufactured by Honshu Chemical Industry Co., Ltd.), NIKALAC MX-290 (trade name, manufactured by Sanwa Chemical Co., Ltd.), 2,6-dimethoxymethyl-4-tert-butylphenol, 2,6-dimethoxymethyl-p-cresol, 2,6-diacetylmethyl-p-cresol, etc.
[0540] Specific examples of the compound represented by formula (AM5) include TriML-P, TriML-35XL, TML-HQ, TML-BP, TML-pp-BPF, TML-BPA, TMOM-BP, HML-TPPHBA, HML-TPHAP, HMOM-TPPHBA, HMOM-TPHAP (these are trade names, manufactured by Honshu Chemical Industry Co., Ltd.), TM-BIP-A (trade name, manufactured by ASAHI YUKIZAI CORPORATION), NIKALAC MX-280, NIKALAC MX-270, and NIKALAC MW-100LM (these are trade names, manufactured by Sanwa Chemical Co., Ltd.).
[0541] -Epoxy compounds (compounds having epoxy groups)-
[0542] As the epoxy compound, a compound having two or more epoxy groups in one molecule is preferred. The epoxy group undergoes a crosslinking reaction below 200°C and does not produce a dehydration reaction derived from the crosslinking, so it is not easy to cause film shrinkage. Therefore, containing an epoxy compound is effective for low-temperature curing of the curable resin composition and suppression of warping.
[0543] The epoxy compound preferably contains a polyethylene oxide group. This further reduces the elastic modulus and suppresses warping. The polyethylene oxide group refers to a group having 2 or more repeating units of ethylene oxide, and the number of repeating units is preferably 2 to 15.
[0544] Examples of epoxy compounds include bisphenol A epoxy resins; bisphenol F epoxy resins; alkylene glycol epoxy resins such as propylene glycol diglycidyl ether; polyalkylene glycol epoxy resins such as polypropylene glycol diglycidyl ether; epoxy group-containing silicones such as polymethyl (glycidyloxypropyl) siloxane, etc., but are not limited to these. Specifically, there can be mentioned EPICLON (registered trademark) 850-S, EPICLON (registered trademark) HP-4032, EPICLON (registered trademark) HP-7200, EPICLON (registered trademark) HP-820, EPICLON (registered trademark) HP-4700, EPICLON (registered trademark) EXA-4710, EPICLON (registered trademark) HP-4770, EPICLON (registered trademark) EXA-859CRP, EPICLON (registered trademark) EXA-1514, EPICLON (registered trademark) EXA-4880, EPICLON ( EPICLON (registered trademark) EXA-4850-150, EPICLON (registered trademark) EXA-4850-1000, EPICLON (registered trademark) EXA-4816, EPICLON (registered trademark) EXA-4822, EPICLON (registered trademark) EXA-830LVP, EPICLON (registered trademark) EXA-8183, EPICLON (registered trademark) EXA-8169, EPICLON (registered trademark) N-660, EPICLON (registered trademark) N-665-EXP-S, EPICLON (registered trademark) N-740 (the above are product names, DIC Corporation), Rika Resin (registered trademark) BEO-20E, Rika Resin (registered trademark) BEO-60E, Rika Resin (registered trademark) HBE-100, Rika Resin (registered trademark) DME-100, Rika Resin (registered trademark) L-200 (trade names, New Japan Chemical Co., Ltd.), EP-4003S, EP-4000S, EP-4088S, EP-3950S (these are trade names, manufactured by ADEKA CORPORATION), CELLOXIDE (registered trademark) 2021P, CELLOXIDE (registered trademark) 2081, CELLOXIDE (registered trademark) 2000, EHPE3150, EPOLEAD (registered trademark) GT401, EPOLEAD (registered trademark) PB4700, EPOLEAD (registered trademark) PB3600 (these are trade names, manufactured by Daicel Corporation), NC-3000, NC-3000-L, NC-3000-H, NC-3000-FH-75M, NC-3100, CER-3000-L, NC-2000-L, XD-1000, NC-7000L, NC-7300L, EPPN-501H, EPPN-501HY, EPPN-502H, EOCN-1020, EOCN-102S, EOCN-103S, EOCN-104S, CER-1020, EPPN-201, BREN-S, BREN-10S (the above are trade names, manufactured by Nippon Kayaku Co., Ltd.), etc. Among them, epoxy resins containing polyethylene oxide groups are preferred from the viewpoint of suppressing warpage and having excellent heat resistance. For example, EPICLON (registered trademark) EXA-4880, EPICLON (registered trademark) EXA-4822, and Rika Resin (registered trademark) BEO-60E contain polyethylene oxide groups and are therefore preferred.
[0545] -Oxycyclobutane compound (compound having an oxycyclobutyl group)-
[0546] Examples of the oxetane compound include compounds having two or more oxetane rings in one molecule, 3-ethyl-3-hydroxymethyloxetane, 1,4-bis{[(3-ethyl-3-oxetane)methoxy]methyl}benzene, 3-ethyl-3-(2-ethylhexylmethyl)oxetane, 1,4-benzenedicarboxylic acid-bis[(3-ethyl-3-oxetane)methyl]ester, etc. As a specific example, ARON OXETANE series (e.g., OXT-121, OXT-221, OXT-191, OXT-223) manufactured by TOAGOSEI CO., LTD. can be preferably used, and these can be used alone or in combination of two or more.
[0547] -Benzoxazine compound (compound having a benzoxazine group)-
[0548] Benzoxazine compounds are preferred because they do not generate outgassing during curing due to a crosslinking reaction caused by a ring-opening addition reaction and further reduce thermal shrinkage to suppress the occurrence of warping.
[0549] Preferred examples of benzoxazine compounds include Ba-type benzoxazine, Bm-type benzoxazine, Pd-type benzoxazine, Fa-type benzoxazine (these are trade names, manufactured by SHIKOKU CHEMICALS CORPORATION), benzoxazine adducts of polyhydroxystyrene resins, and phenol novolac-type dihydrobenzoxazine compounds. These may be used alone or in combination of two or more.
[0550] When a polymerizable compound is contained, its content is preferably more than 0% by mass and less than 60% by mass relative to the total solid content of the curable resin composition of the present invention. The lower limit is more preferably more than 5% by mass. The upper limit is more preferably less than 50% by mass, and further preferably less than 30% by mass.
[0551] The polymerizable compound may be used alone or in combination of two or more. When two or more are used simultaneously, the total amount thereof is preferably within the above range.
[0552] <Migration inhibitor>
[0553] The curable resin composition of the present invention preferably further contains a migration inhibitor. By containing the migration inhibitor, it is possible to effectively suppress the migration of metal ions originating from the metal layer (metal wiring) into the curable resin composition layer.
[0554] The migration inhibitor is not particularly limited, and examples thereof include compounds having a heterocyclic ring (pyrrole ring, furan ring, thiophene ring, imidazole ring, oxazole ring, thiazole ring, pyrazole ring, isoxazole ring, isothiazole ring, tetrazole ring, pyridine ring, pyridazine ring, pyrimidine ring, pyrazine ring, piperidine ring, piperazine ring, morpholine ring, 2H-pyran ring, 6H-pyran ring, triazine ring), thioureas, compounds having a sulfhydryl group, hindered phenol compounds, salicylic acid derivative compounds, and hydrazide derivative compounds. In particular, triazole compounds such as 1,2,4-triazole and benzotriazole, and tetrazole compounds such as 1H-tetrazole and 5-phenyltetrazole can be preferably used.
[0555] Alternatively, an ion trapping agent that traps anions such as halogen ions may also be used.
[0556] As other migration inhibitors, the rust inhibitors described in paragraph 0094 of JP-A-2013-015701, the compounds described in paragraphs 0073 to 0076 of JP-A-2009-283711, the compounds described in paragraph 0052 of JP-A-2011-059656, the compounds described in paragraphs 0114, 0116, and 0118 of JP-A-2012-194520, the compounds described in paragraph 0166 of International Publication No. 2015 / 199219, etc. can be used.
[0557] Specific examples of the migration inhibitor include the following compounds.
[0558] [Chemical formula 47]
[0559]
[0560] When the curable resin composition contains a migration inhibitor, the content of the migration inhibitor is preferably 0.01 to 5.0 mass %, more preferably 0.05 to 2.0 mass %, and even more preferably 0.1 to 1.0 mass % based on the total solid content of the curable resin composition.
[0561] The migration inhibitor may be one kind or two or more kinds. When there are two or more kinds of migration inhibitors, the total amount thereof is preferably within the above range.
[0562] <Polymerization inhibitor>
[0563] The curable resin composition of the present invention preferably contains a polymerization inhibitor.
[0564] As the polymerization inhibitor, for example, hydroquinone, p-methoxyphenol, di-tert-butyl-p-cresol, gallol, p-tert-butylcatechol, 1,4-benzoquinone, diphenyl-p-benzoquinone, 4,4′-thiobis(3-methyl-6-tert-butylphenol), 2,2′-methylenebis(4-methyl-6-tert-butylphenol), N-nitroso-N-phenylhydroxylamine aluminum salt, phenothiazine, N-nitrosodiphenylamine, N-phenylnaphthylamine, ethylenediaminetetraacetic acid, 1,2-cyclohexanediaminetetraacetic acid, glycol ether diaminetetraacetic acid, 2,6-di-tert-butyl-4-methylphenol, 5-nitroso-8-hydroxyquinoline, 1-nitroso-2-naphthol, 2-nitroso-1-naphthol, 2 -Nitroso-5-(N-ethyl-N-sulfopropylamino)phenol, N-nitroso-N-(1-naphthyl)hydroxylamine ammonium salt, bis(4-hydroxy-3,5-tert-butyl)phenylmethane, o-methoxyphenol, N-nitrosophenylhydroxylamine first cerium salt, 1,3,5-tris(4-tert-butyl-3-hydroxy-2,6-dimethylbenzyl)-1,3,5-triazine-2,4,6-(1H,3H,5H)-trione, 4-hydroxy-2,2,6,6-tetramethylpiperidinium 1-oxyl free radical, 1,1-diphenyl-2-picrylhydrazine, dibutyl dithiocarbamate copper (II), nitrobenzene, N-nitroso-N-phenylhydroxylamine aluminum salt, N-nitroso-N-phenylhydroxylamine ammonium salt, etc. Furthermore, the polymerization inhibitors described in paragraph 0060 of JP-A-2015-127817 and the compounds described in paragraphs 0031 to 0046 of WO-2015 / 125469 can also be used.
[0565] Furthermore, the following compounds (Me is methyl group) can be used.
[0566] [Chemical formula 48]
[0567]
[0568] When the curable resin composition of the present invention contains a polymerization inhibitor, the content of the polymerization inhibitor may be, for example, 0.01 to 20.0% by mass, preferably 0.01 to 5% by mass, more preferably 0.02 to 3% by mass, and still more preferably 0.05 to 2.5% by mass relative to the total solid content of the curable resin composition of the present invention. Furthermore, when the storage stability of the curable resin composition solution is required, the content of the polymerization inhibitor may be preferably 0.02 to 15.0% by mass, in which case it is more preferably 0.05 to 10.0% by mass.
[0569] The polymerization inhibitor may be one kind or two or more kinds. When there are two or more kinds of polymerization inhibitors, the total amount thereof is preferably within the above range.
[0570] <Metal Adhesion Improver>
[0571] The curable resin composition of the present invention preferably contains a metal adhesion improver for improving adhesion to metal materials used in electrodes or wiring, etc. Examples of the metal adhesion improver include silane coupling agents, aluminum-based adhesion aids, titanium-based adhesion aids, compounds having a sulfonamide structure and compounds having a thiourea structure, phosphoric acid derivative compounds, β-ketoester compounds, and amino compounds.
[0572] Examples of silane coupling agents include compounds described in paragraph 0167 of International Publication No. 2015 / 199219, compounds described in paragraphs 0062 to 0073 of Japanese Patent Application Laid-Open No. 2014-191002, compounds described in paragraphs 0063 to 0071 of International Publication No. 2011 / 080992, compounds described in paragraphs 0060 to 0061 of Japanese Patent Application Laid-Open No. 2014-191252, compounds described in paragraphs 0045 to 0052 of Japanese Patent Application Laid-Open No. 2014-041264, and compounds described in paragraph 0055 of International Publication No. 2014 / 097594. It is also preferred to use two or more different silane coupling agents as described in paragraphs 0050 to 0058 of Japanese Patent Application Laid-Open No. 2011-128358. Furthermore, it is also preferable to use the following compounds as the silane coupling agent: In the following formula, Et represents an ethyl group.
[0573] [Chemical formula 49]
[0574]
[0575] Examples of other silane coupling agents include vinyl trimethoxysilane, vinyl triethoxysilane, 2-(3,4-epoxycyclohexyl)ethyl trimethoxysilane, 3-glycidoxypropyl methyl dimethoxysilane, 3-glycidoxypropyl trimethoxysilane, 3-glycidoxypropyl methyl diethoxysilane, 3-glycidoxypropyl triethoxysilane, p-phenylenediyl trimethoxysilane, 3-methacryloxypropyl methyl dimethoxysilane, 3-methacryloxypropyl trimethoxysilane, 3-methacryloxypropyl methyl diethoxysilane, 3-methacryloxypropyl triethoxysilane, 3-acryloxypropyl propyltrimethoxysilane, N-2-(aminoethyl)-3-aminopropylmethyldimethoxysilane, N-2-(aminoethyl)-3-aminopropyltrimethoxysilane, 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 3-triethoxysilyl-N-(1,3-dimethyl-butylene)propylamine, N-phenyl-3-aminopropyltrimethoxysilane, tris-(trimethoxysilylpropyl)isocyanurate, 3-ureidopropyltrialkoxysilane, 3-mercaptopropylmethyldimethoxysilane, 3-mercaptopropyltrimethoxysilane, 3-isocyanatepropyltriethoxysilane, 3-trimethoxysilylpropylsuccinic anhydride. These can be used alone or in combination of two or more.
[0576] Furthermore, as the metal adhesion improver, the compounds described in paragraphs 0046 to 0049 of JP-A-2014-186186 and the sulfide compounds described in paragraphs 0032 to 0043 of JP-A-2013-072935 can also be used.
[0577] 〔Aluminum-based adhesive additive〕
[0578] Examples of the aluminum-based adhesion promoter include tris(ethyl acetoacetate)aluminum, tris(acetylacetonate)aluminum, and ethyl acetoacetate aluminum diisopropyl.
[0579] The content of the metal adhesion improver is preferably in the range of 0.1 to 30 parts by mass, more preferably in the range of 0.5 to 15 parts by mass, and further preferably in the range of 0.5 to 5 parts by mass, relative to 100 parts by mass of the polymer precursor containing the heterocycle. By setting it to above the above lower limit, the adhesion between the cured film after the curing process and the metal layer becomes good, and by setting it to below the above upper limit, the heat resistance and mechanical properties of the cured film after the curing process become good. The metal adhesion improver may be only one or more than two. When using two or more, it is preferred that the total is within the above range.
[0580] <Other additives>
[0581] The curable resin composition of the present invention may be formulated with various additives as needed within the range in which the effects of the present invention can be obtained, such as a thermal acid generator, a sensitizer such as N-phenyldiethanolamine, a chain transfer agent, a surfactant, a higher fatty acid derivative, an inorganic particle, a curing agent, a curing catalyst, a filler, an antioxidant, an ultraviolet absorber, an anticoagulant, etc. When these additives are formulated, it is preferred that the total amount thereof be set to 3% by mass or less of the solid content of the curable resin composition.
[0582] 〔Sensitizer〕
[0583] The curable resin composition of the present invention may contain a sensitizer. The sensitizer absorbs specific active radiation and becomes an electronically excited state. The sensitizer in the electronically excited state contacts with a thermal curing accelerator, a thermal free radical polymerization initiator, a photo-free radical polymerization initiator, etc. to generate electron transfer, energy transfer, heat generation, etc. As a result, the thermal curing accelerator, the thermal free radical polymerization initiator, and the photo-free radical polymerization initiator undergo chemical changes and decompose, thereby generating free radicals, acids, or bases.
[0584] As the sensitizer, there can be mentioned sensitizers such as N-phenyldiethanolamine. In addition, compounds such as benzophenone, michler's ketone, coumarin, pyrazole azo, anilino azo, triphenylmethane, anthraquinone, anthracene, anthrapyridone, benzylidene, oxonol, pyrazolotriazole azo, pyridone azo, cyanine, phenothiazine, pyrrolopyrazole methine azo, xanthene, phthalocyanine, benzopyran, and indigo can be used.
[0585] For example, Michelle's ketone, 4,4'-bis(diethylamino)benzophenone, 2,5-bis(4'-diethylaminobenzylidene)cyclopentane, 2,6-bis(4'-diethylaminobenzylidene)cyclohexanone, 2,6-bis(4'-diethylaminobenzylidene)-4-methylcyclohexanone, 4,4'-bis(dimethylamino)chalcone, 4,4'-bis(diethylamino)chalcone, p-dimethylaminophenylallyl (cinnamylidene) dihydroindane, ketone, p-dimethylaminobenzylidene dihydroindanone, 2-(p-dimethylaminophenyl biphenylene)-benzothiazole, 2-(p-dimethylaminophenyl vinylene)benzothiazole, 2-(p-dimethylaminophenyl vinylene)isonaphthothiazole, 1,3-bis(4'-dimethylaminobenzylidene)acetone, 1,3-bis(4'-diethylaminobenzylidene)acetone, 3,3'-carbonyl-bis(7-diethylaminocoumarin), 3-acetyl-7-dimethylaminocoumarin , 3-ethoxycarbonyl-7-dimethylaminocoumarin, 3-benzyloxycarbonyl-7-dimethylaminocoumarin, 3-methoxycarbonyl-7-diethylaminocoumarin, 3-ethoxycarbonyl-7-diethylaminocoumarin (7-(diethylamino)coumarin-3-carboxylic acid ethyl ester), N-phenyl-N'-ethylethanolamine, N-phenyldiethanolamine, N-p-tolyldiethanolamine, N-phenylethanolamine, 4-morpholinobenzophenone, isopentyl dimethylaminobenzoate, Isoamyl diethylaminobenzoate, 2-mercaptobenzimidazole, 1-phenyl-5-mercaptotetrazole, 2-mercaptobenzothiazole, 2-(p-dimethylaminophenylvinyl)benzoxazole, 2-(p-dimethylaminophenylvinyl)benzothiazole, 2-(p-dimethylaminophenylvinyl)naphtho(1,2-d)thiazole, 2-(p-dimethylaminobenzoyl)styrene, diphenylacetamide, benzanilide, N-methylacetanilide, 3',4'-dimethylacetanilide, etc.
[0586] Furthermore, a sensitizing dye may be used as the sensitizer.
[0587] For details of the sensitizing dye, reference can be made to paragraphs 0161 to 0163 of JP-A-2016-027357, and the contents are incorporated into the present specification.
[0588] When the curable resin composition of the present invention contains a sensitizer, the content of the sensitizer is preferably 0.01 to 20 mass %, more preferably 0.1 to 15 mass %, and further preferably 0.5 to 10 mass % relative to the total solid content of the curable resin composition of the present invention. The sensitizer may be used alone or in combination of two or more.
[0589] 〔Chain transfer agent〕
[0590] The curable resin composition of the present invention may contain a chain transfer agent. Chain transfer agents are defined, for example, in the third edition of the Polymer Dictionary (edited by the Polymer Society, 2005), pages 683-684. As chain transfer agents, for example, a polymer having -SS-, -SO- 2 -S-, -NO-, SH, PH, SiH and GeH compound groups, dithiobenzoate, trithiocarbonate, dithiocarbamate, xanthate compounds having thiocarbonylthio group used in RAFT (Reversible Addition Fragmentation Chain Transfer) polymerization, etc. These can generate free radicals by supplying hydrogen to low-activity free radicals, or generate free radicals by deprotonation after oxidation. In particular, thiol compounds can be preferably used.
[0591] Furthermore, as the chain transfer agent, the compounds described in paragraphs 0152 to 0153 of International Publication No. 2015 / 199219 can also be used.
[0592] When the curable resin composition of the present invention has a chain transfer agent, the content of the chain transfer agent is preferably 0.01 to 20 parts by mass, more preferably 1 to 10 parts by mass, and further preferably 1 to 5 parts by mass relative to 100 parts by mass of the total solid content of the curable resin composition of the present invention. The chain transfer agent may be only one or more than two. When there are two or more chain transfer agents, it is preferred that the total is within the above range.
[0593] 〔Surfactant〕
[0594] From the viewpoint of further improving the coating property, various types of surfactants can be added to the curable resin composition of the present invention. As surfactants, various surfactants such as fluorine-based surfactants, nonionic surfactants, cationic surfactants, anionic surfactants, silicone surfactants can be used. And, the following surfactants are also preferred. In the following formula, the brackets representing the repeating units of the main chain represent the content (mol %) of each repeating unit, and the brackets representing the repeating units of the side chains represent the number of repetitions of each repeating unit.
[0595] [Chemical formula 50]
[0596]
[0597] Furthermore, as the surfactant, the compounds described in paragraphs 0159 to 0165 of International Publication No. 2015 / 199219 can also be used.
[0598] When the curable resin composition of the present invention has a surfactant, the content of the surfactant is preferably 0.001 to 2.0 mass %, more preferably 0.005 to 1.0 mass % relative to the total solid content of the curable resin composition of the present invention. The surfactant may be only one or more than two. When there are two or more surfactants, it is preferred that the total is within the above range.
[0599] 〔Higher fatty acid derivatives〕
[0600] In order to prevent polymerization inhibition caused by oxygen, a higher fatty acid derivative such as behenic acid or behenic acid amide may be added to the curable resin composition of the present invention so as to be unevenly distributed on the surface of the curable resin composition during the drying process after coating.
[0601] Furthermore, as the higher fatty acid derivatives, the compounds described in paragraph 0155 of International Publication No. 2015 / 199219 can also be used.
[0602] When the curable resin composition of the present invention has a higher fatty acid derivative, the content of the higher fatty acid derivative is preferably 0.1 to 10% by mass relative to the total solid content of the curable resin composition of the present invention. The higher fatty acid derivative may be only one or two or more. When there are two or more higher fatty acid derivatives, it is preferred that the total is within the above range.
[0603] <Regulation on other substances contained>
[0604] From the viewpoint of coating surface properties, the water content of the curable resin composition of the present invention is preferably less than 5 mass %, more preferably less than 1 mass %, and further preferably less than 0.6 mass %.
[0605] From the viewpoint of insulation, the metal content of the curable resin composition of the present invention is preferably less than 5 mass ppm (parts per million), more preferably less than 1 mass ppm, and further preferably less than 0.5 mass ppm. Examples of the metal include sodium, potassium, magnesium, calcium, iron, chromium, nickel, etc. When multiple metals are included, it is preferred that the total amount of these metals is within the above range.
[0606] In addition, as a method for reducing metal impurities unintentionally contained in the curable resin composition of the present invention, the following methods can be cited: selecting a raw material with a low metal content as a raw material constituting the curable resin composition of the present invention; filtering the raw material constituting the curable resin composition of the present invention; lining the inside of the apparatus with polytetrafluoroethylene or the like to perform distillation under conditions that minimize contamination.
[0607] In the curable resin composition of the present invention, if the use as a semiconductor material is considered, the content of halogen atoms is preferably less than 500 mass ppm, more preferably less than 300 mass ppm, and further preferably less than 200 mass ppm from the viewpoint of wiring corrosion. Among them, the substance existing in the state of halogen ions is preferably less than 5 mass ppm, more preferably less than 1 mass ppm, and further preferably less than 0.5 mass ppm. As halogen atoms, chlorine atoms and bromine atoms can be cited. Preferably, the total of chlorine atoms and bromine atoms, or chlorine ions and bromide ions is within the above range.
[0608] As the storage container of the curable resin composition of the present invention, a conventionally known storage container can be used. In addition, as the storage container, for the purpose of suppressing the mixing of impurities into the raw materials or the curable composition, it is also preferred to use a multilayer bottle having a container inner wall made of 6 kinds of 6 layers of resin or a bottle having a 7-layer structure made of 6 kinds of resin. As such a container, for example, the container described in Japanese Patent Publication No. 2015-123351 can be cited.
[0609] <Application of curable resin composition>
[0610] The curable resin composition of the present invention is preferably used for forming an interlayer insulating film for a rewiring layer.
[0611] Furthermore, the present invention can also be used for forming an insulating film or a stress buffer film of a semiconductor device.
[0612] (Method for producing curable resin composition)
[0613] The method for producing the curable resin composition of the present invention is preferably a method comprising the step of mixing the above-mentioned components contained in the curable resin composition. The mixing method is not particularly limited, and can be performed by a conventionally known method.
[0614] Furthermore, the method for producing the curable resin composition of the present invention is preferably a method for producing a composition comprising a polymer precursor containing a heterocyclic ring, the polymerization initiator and the solvent (hereinafter, also referred to as a precursor composition) and a specific compound. The mixing method is not particularly limited and can be performed using a conventionally known method.
[0615] The precursor composition may further contain the components contained in the curable resin composition of the present invention, such as the radical polymerizable compound, the onium salt, and the thermal base generator, as necessary.
[0616] The precursor composition is preferably a composition having a composition obtained by removing a specific compound from the curable resin composition of the present invention.
[0617] In the production method using the above-mentioned precursor composition, the precursor composition can be obtained by purchasing or the like, and the above-mentioned production method can further include a step of mixing the components contained in the precursor composition to prepare the precursor composition. The mixing method is not particularly limited and can be performed using a conventionally known method.
[0618] In the production method using the above-mentioned precursor composition, the specific compound can be added, for example, immediately before forming a film from the curable resin composition.
[0619] Furthermore, for the purpose of removing foreign matter such as dust or particles in the curable resin composition, it is preferred to filter using a filter. The filter pore size can be, for example, 5 μm or less, preferably 1 μm or less, more preferably 0.5 μm or less, and further preferably 0.1 μm or less. The material of the filter is preferably polytetrafluoroethylene, polyethylene or nylon. The filter can use a filter that has been pre-cleaned with an organic solvent. In the filter filtering process, a variety of filters can be connected in series or in parallel. When using a variety of filters, filters with different pore sizes or materials can be used in combination. In addition, various materials can be filtered multiple times. When filtered multiple times, it can be a circulation filter. In addition, it can be filtered by pressurization. When filtering by pressurization, the pressurization pressure can be, for example, 0.01MPa or more and 1.0MPa or less, preferably 0.03MPa or more and 0.9MPa or less, more preferably 0.05MPa or more and 0.7MPa or less, and further preferably 0.05MPa or more and 0.3MPa or less.
[0620] In addition to filtering using a filter, impurity removal using an adsorbent may also be performed. Filter filtering and impurity removal using an adsorbent may also be combined. As the adsorbent, a known adsorbent may be used. For example, inorganic adsorbents such as silica gel and zeolite, and organic adsorbents such as activated carbon may be cited.
[0621] (Cured film, laminated body, semiconductor device, and method for producing the same)
[0622] Next, a cured film, a laminated body, a semiconductor device, and methods for producing these will be described.
[0623] The cured film of the present invention is formed by curing the curable resin composition of the present invention. The film thickness of the cured film of the present invention can be set to 0.5 μm or more, or 1 μm or more, and the upper limit can be set to 100 μm or less, or 30 μm or less.
[0624] The cured film of the present invention can be stacked in two or more layers, and further stacked in 3 to 7 layers to form a laminate. The laminate of the present invention is preferably a form comprising two or more cured films and a metal layer between any of the above-mentioned cured films. For example, a laminate having a layer structure comprising at least three layers of a first cured film, a metal layer, and a second cured film stacked in sequence can be cited as a preferred laminate. The first cured film and the second cured film are both the cured films of the present invention. For example, a form in which the first cured film and the second cured film are both films formed by curing the curable resin composition of the present invention can be cited as a preferred form. The curable resin composition of the present invention used for the formation of the first cured film and the curable resin composition of the present invention used for the formation of the second cured film can be a composition of the same composition or a composition of different composition. The metal layer in the laminate of the present invention can be preferably used as a metal wiring of a redistribution layer, etc.
[0625] As the fields to which the cured film of the present invention can be applied, there can be cited insulating films of semiconductor devices, interlayer insulating films for rewiring layers, stress buffer films, etc. In addition, there can be cited the formation of patterns on sealing films, substrate materials (base films or cover films of flexible printed boards, interlayer insulating films), or insulating films for packaging purposes as described above by etching, etc. For the use of these, for example, reference can be made to SCIENCE AND TECHNOLOGY CO., LTD. "High Functionalization and Application Technology of Polyimide" April 2008, supervised by Masaaki Kakimoto, CMC Technical Library "Basics and Development of Polyimide Materials" November 2011, "Latest Polyimide Basics and Applications" compiled by the Japanese Polyimide and Aromatic Polymer Research Association, NTS Inc., August 2010, etc.
[0626] Furthermore, the cured film of the present invention can also be used in the production of printing plates such as offset printing plates and screen printing plates, in the etching of molded components, and in the production of protective varnishes and dielectric layers in electronics, especially microelectronics.
[0627] The method for producing a cured film of the present invention (hereinafter, also simply referred to as “the production method of the present invention”) preferably includes a film forming step of applying the curable resin composition of the present invention to a substrate to form a film.
[0628] The method for producing a cured film of the present invention also preferably includes a step of mixing the above-mentioned precursor composition and a specific compound to produce the curable resin composition of the present invention before the above-mentioned film forming step.
[0629] The method for producing a cured film of the present invention preferably includes the film forming step, an exposure step of exposing the film to light, and a development step of developing the film.
[0630] Furthermore, the method for producing a cured film of the present invention more preferably includes the film forming step and, if necessary, the developing step, and includes a heating step of heating the film at 50 to 450°C.
[0631] Specifically, it is also preferable to include the following steps (a) to (d). Furthermore, if necessary, the step (a') may be included before (a).
[0632] (a') Composition production step of mixing a precursor composition and a specific compound to produce the curable resin composition of the present invention
[0633] (a) Film formation step of applying a curable resin composition to a substrate to form a film (curable resin composition layer)
[0634] (b) After the film forming step, an exposure step of exposing the film to light
[0635] (c) A developing step of developing the exposed film
[0636] (d) a heating step of heating the developed film at 50 to 450° C.
[0637] By heating in the heating step, the resin layer cured by exposure can be further cured. In the heating step, for example, the thermal base generator is decomposed to obtain sufficient curability.
[0638] The method for manufacturing a laminated body according to a preferred embodiment of the present invention includes a method for manufacturing a cured film according to the present invention. After forming a cured film according to the method for manufacturing a laminated body of the present embodiment, the process (a) or the processes (a) to (c) or the processes (a) to (d) are further performed again. In particular, the above-mentioned processes are performed in sequence multiple times, preferably, for example, 2 to 5 times (i.e., 3 to 6 times in total). By stacking the cured films in this way, a laminated body can be made. It is preferred that in the present invention, a metal layer is provided, especially on a portion where a cured film is provided or between the cured films, or on a portion where a cured film is provided and between the cured films. In addition, when manufacturing a laminated body, it is not necessary to repeatedly perform all the processes (a) to (d). As described above, by performing at least multiple times of (a), preferably (a) to (c) or (a) to (d), a laminated body of a cured film can be obtained.
[0639] When the step (a) is performed multiple times, the step (a') may be further performed before each step (a), or the curable resin composition produced in the step (a') once may be used in multiple steps (a).
[0640] <Film forming step (layer forming step)>
[0641] The production method according to a preferred embodiment of the present invention includes a film forming step (layer forming step) of applying a curable resin composition to a substrate to form a film (layer).
[0642] The type of substrate can be appropriately specified according to the intended use, and may be a semiconductor substrate such as silicon, silicon nitride, polycrystalline silicon, silicon oxide, amorphous silicon, quartz, glass, optical film, ceramic material, vapor-deposited film, magnetic film, reflective film, metal substrate such as Ni, Cu, Cr, Fe, paper, SOG (Spin On Glass), TFT (Thin Film Transistor) array substrate, electrode plate of plasma display panel (PDP), etc., without any particular restrictions.
[0643] In the present invention, a semiconductor manufacturing substrate is particularly preferred, and a silicon substrate or a mold resin substrate is more preferred.
[0644] Furthermore, as the base material, for example, a plate-shaped base material (substrate) can be used.
[0645] Furthermore, when a curable resin composition layer is formed on the surface of a resin layer or the surface of a metal layer, the resin layer or the metal layer serves as a substrate.
[0646] As a method of applying the curable resin composition to a substrate, coating is preferred.
[0647] Specifically, as the applicable method, dip coating, air knife coating, curtain coating, wire rod coating, gravure coating, extrusion coating, spray coating, spin coating, slit coating and inkjet can be exemplified. From the perspective of uniformity of the thickness of the curable resin composition layer, spin coating, slit coating, spray coating, and inkjet are more preferred. By appropriately adjusting the solid content concentration or coating conditions according to the method, a resin layer of a desired thickness can be obtained.
[0648] Furthermore, the coating method can be appropriately selected according to the shape of the substrate. If it is a circular substrate such as a wafer, it is preferably a spin coating method, a spray coating method, an inkjet method, etc. If it is a rectangular substrate, it is preferably a slit coating method, a spray coating method, an inkjet method, etc. In the case of spin coating, for example, it can be applied at a rotation speed of 300 to 3,500 rpm for 10 to 180 seconds, and it can be applied at a rotation speed of 500 to 2,000 rpm for about 10 seconds to 1 minute. In addition, in order to obtain uniform film thickness, multiple rotation speeds can be combined for coating.
[0649] Furthermore, a method of transferring a coating film formed on a temporary support body by the above-mentioned imparting method in advance to a substrate can also be applied.
[0650] Regarding the transfer method, the production method described in paragraphs 0023 and 0036 to 0051 of Japanese Patent Application Laid-Open No. 2006-023696 or paragraphs 0096 to 0108 of Japanese Patent Application Laid-Open No. 2006-047592 can also be preferably used in the present invention.
[0651] <Drying process>
[0652] The manufacturing method of the present invention may include a drying step for removing the solvent after the film forming step (layer forming step) after forming the above-mentioned film (curable resin composition layer). The preferred drying temperature is 50 to 150°C, more preferably 70°C to 130°C, and further preferably 90°C to 110°C. As the drying time, 30 seconds to 20 minutes can be exemplified, preferably 1 minute to 10 minutes, and more preferably 3 minutes to 7 minutes. When the amount of solvent in the curable resin composition solution is large, vacuum drying and heat drying can also be combined. Heat drying can use a heating plate, a hot air oven, etc., without particular limitation.
[0653] <Exposure process>
[0654] The manufacturing method of the present invention may include an exposure step of exposing the film (curable resin composition layer). The exposure amount is not particularly limited as long as the curable resin composition can be cured, but for example, it is preferably 100 to 10,000 mJ / cm2 in terms of exposure energy at a wavelength of 365 nm. 2 , more preferably irradiation 200 to 8,000 mJ / cm 2 .
[0655] The exposure wavelength can be appropriately set within the range of 190 to 1,000 nm, and is preferably 240 to 550 nm.
[0656] When the exposure wavelength is explained in relation to the light source, it can be exemplified by (1) semiconductor lasers (wavelengths of 830 nm, 532 nm, 488 nm, 405 nm, etc.), (2) metal halide lamps, (3) high pressure mercury lamps, g-rays (wavelength 436 nm), h-rays (wavelength 405 nm), i-rays (wavelength 365 nm), broadband (three wavelengths of g, h, and i-rays), (4) excimer lasers, KrF excimer lasers (wavelength 248 nm), ArF excimer lasers (wavelength 193 nm), F 2Excimer laser (wavelength 157nm), (5) extreme ultraviolet light; EUV (wavelength 13.6nm), (6) electron beam, (7) second harmonic 532nm and third harmonic 355nm of YAG laser, etc. For the curable resin composition of the present invention, exposure based on a high-pressure mercury lamp is particularly preferred, and exposure based on i-rays is preferred. In this way, particularly high exposure sensitivity can be obtained. In addition, from the perspective of operation and productivity, a wide (three wavelengths of g, h, and i-rays) light source of a high-pressure mercury lamp or a semiconductor laser 405nm is also preferred.
[0657] <Development process>
[0658] The manufacturing method of the present invention may include a developing step of developing the exposed film (curable resin composition layer) (developing the above film). The unexposed portion (non-exposed portion) is removed by developing. The developing method is not particularly limited as long as the desired pattern can be formed, and for example, a developing method such as a coating, spraying, dipping, or ultrasonic wave can be used.
[0659] The development is performed using a developer. The developer can be used without particular limitation as long as it can remove the unexposed portion (non-exposed portion).
[0660] In the present invention, the developer preferably contains an organic solvent having a ClogP value of -1 to 5, and more preferably contains an organic solvent having a ClogP value of 0 to 3. The ClogP value can be obtained as a calculated value by inputting the structural formula into ChemBioDraw.
[0661] As for the organic solvent, examples of esters preferably include ethyl acetate, n-butyl acetate, amyl formate, isoamyl acetate, isobutyl acetate, butyl propionate, isopropyl butyrate, ethyl butyrate, butyl butyrate, methyl lactate, ethyl lactate, γ-butyrolactone, ε-caprolactone, δ-valerolactone, alkyl alkoxyacetates (e.g., methyl alkoxyacetate, ethyl alkoxyacetate, butyl alkoxyacetate (e.g., methyl methoxyacetate, ethyl methoxyacetate, butyl methoxyacetate, methyl ethoxyacetate, ethyl ethoxyacetate, etc.)), 3-Alkoxypropionic acid alkyl esters (e.g., 3-alkoxypropionic acid methyl ester, 3-alkoxypropionic acid ethyl ester, etc. (e.g., 3-methoxypropionic acid methyl ester, 3-methoxypropionic acid ethyl ester, 3-ethoxypropionic acid methyl ester, 3-ethoxypropionic acid ethyl ester, etc.)), 2-alkoxypropionic acid alkyl esters (e.g., 2-alkoxypropionic acid methyl ester, 2-alkoxypropionic acid ethyl ester, 2-alkoxypropionic acid propyl ester, etc. (e.g., 2-methoxypropionic acid methyl ester, 2-methoxypropionic acid ethyl ester, 2-methoxypropionic acid propyl ester, 2-ethoxypropionic acid methyl ester, 2-ethoxypropionic acid ethyl ester) )), methyl 2-alkoxy-2-methylpropionate and ethyl 2-alkoxy-2-methylpropionate (for example, methyl 2-methoxy-2-methylpropionate, ethyl 2-ethoxy-2-methylpropionate, etc.), methyl pyruvate, ethyl pyruvate, propyl pyruvate, methyl acetoacetate, ethyl acetoacetate, methyl 2-oxobutyrate, ethyl 2-oxobutyrate, and the like, and, as ethers, for example, diethylene glycol dimethyl ether, tetrahydrofuran, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, methyl celulose acetate, ethyl celulose acetate , diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monobutyl ether, propylene glycol monomethyl ether, propylene glycol monomethyl ether acetate, propylene glycol monoethyl ether acetate, propylene glycol monopropyl ether acetate, etc., and, as ketones, for example, methyl ethyl ketone, cyclohexanone, cyclopentanone, 2-heptanone, 3-heptanone, N-methyl-2-pyrrolidone, etc., and as cyclic hydrocarbons, for example, aromatic hydrocarbons such as toluene, xylene, anisole, cyclic terpenes such as limonene, etc., can be preferably mentioned, and as sulfoxides, dimethyl sulfoxide can be preferably mentioned.
[0662] In the present invention, cyclopentanone and γ-butyrolactone are particularly preferred, and cyclopentanone is more preferred.
[0663] Furthermore, the developer may contain a surfactant.
[0664] The developer preferably contains 50% by mass or more of an organic solvent, more preferably 70% by mass or more of an organic solvent, and even more preferably 90% by mass or more of an organic solvent. Alternatively, the developer may contain 100% by mass of an organic solvent.
[0665] The development time is preferably 10 seconds to 5 minutes. The temperature of the developer during development is not particularly limited, but the development can be performed usually at 20 to 40°C.
[0666] After the treatment with the developer, rinsing may be further performed. The rinsing is preferably performed in a solvent different from the developer. For example, propylene glycol monomethyl ether acetate can be cited. The rinsing time is preferably 5 seconds to 5 minutes. In addition, a process of applying both the developer and the rinsing solution may be included between development and rinsing. The time of the above process is preferably 1 second to 5 minutes. For example, rinsing can be performed using a solvent contained in the curable resin composition. The rinsing time is preferably 5 seconds to 1 minute.
[0667] <Heating process>
[0668] The production method of the present invention preferably includes a step of heating the developed film at 50 to 450° C. (heating step).
[0669] It is preferred that a heating step is included after the film forming step (layer forming step), the drying step and the developing step. In the heating step, for example, the cyclization reaction of the polymer precursor containing a heterocyclic ring is carried out by generating a base by decomposing the above-mentioned thermal base generating agent. In addition, the curable resin composition of the present invention may contain a radical polymerizable compound other than the polymer precursor containing a heterocyclic ring, and the curing of the radical polymerizable compound other than the unreacted polymer precursor containing a heterocyclic ring can also be carried out in this step. As the heating temperature (maximum heating temperature) of the layer in the heating step, it is preferably 50°C or more, more preferably 80°C or more, more preferably 140°C or more, more preferably 150°C or more, more preferably 160°C or more, and even more preferably 170°C or more. As an upper limit, it is preferably 500°C or less, more preferably 450°C or less, more preferably 350°C or less, more preferably 250°C or less, and even more preferably 220°C or less.
[0670] The heating is preferably performed at a heating rate of 1 to 12°C / min, more preferably 2 to 10°C / min, and even more preferably 3 to 10°C / min, from the temperature at the start of heating to the maximum heating temperature. By setting the heating rate to 1°C / min or more, productivity can be ensured while preventing excessive volatilization of amines, and by setting the heating rate to 12°C / min or less, residual stress in the cured film can be reduced.
[0671] The temperature at the start of heating is preferably 20°C to 150°C, more preferably 20°C to 130°C, and further preferably 25°C to 120°C. The temperature at the start of heating refers to the temperature at the start of the process of heating to the maximum heating temperature. For example, when the curable resin composition is applied to a substrate and then dried, it refers to the temperature of the dried film (layer), for example, preferably starting from a temperature 30 to 200°C lower than the boiling point of the solvent contained in the curable resin composition and gradually heating up.
[0672] The heating time (heating time at the maximum heating temperature) is preferably 10 to 360 minutes, more preferably 20 to 300 minutes, and even more preferably 30 to 240 minutes.
[0673] In particular, when a multilayer laminate is formed, from the viewpoint of the adhesion between the layers of the cured film, the heating temperature is preferably 180° C. to 320° C., and more preferably 180° C. to 260° C. The reason for this is not clear, but it is believed that the acetylene groups of the heterocyclic ring-containing polymer precursor between the layers undergo cross-linking reactions.
[0674] Heating can be performed in stages. As an example, the following pretreatment process can be performed: heating from 25°C to 180°C at 3°C / min, maintaining at 180°C for 60 minutes, heating from 180°C to 200°C at 2°C / min, and maintaining at 200°C for 120 minutes. The heating temperature of the pretreatment process is preferably 100-200°C, more preferably 110-190°C, and further preferably 120-185°C. In this pretreatment process, as described in the specification of U.S. Patent No. 9159547, it is also preferred to treat while irradiating ultraviolet rays. Through this pretreatment process, the properties of the film can be further improved. The pretreatment process can be performed in a short time of about 10 seconds to 2 hours, more preferably 15 seconds to 30 minutes. The pretreatment can also be set as a step of more than 2 stages, for example, pretreatment process 1 can be performed in the range of 100-150°C, and then pretreatment process 2 can be performed in the range of 150-200°C.
[0675] The heating may be followed by cooling, and the cooling rate at this time is preferably 1 to 5° C. / min.
[0676] From the viewpoint of preventing the decomposition of the polymer precursor containing the heterocyclic ring, the heating step is preferably carried out in an atmosphere of low oxygen concentration by passing an inert gas such as nitrogen, helium, argon, etc., under vacuum, etc. The oxygen concentration is preferably 50 ppm (volume ratio) or less, more preferably 20 ppm (volume ratio) or less.
[0677] <Metal layer forming step>
[0678] The production method of the present invention preferably includes a metal layer forming step of forming a metal layer on the surface of the developed film (curable resin composition layer).
[0679] The metal layer is not particularly limited, and any conventional metal can be used. Examples thereof include copper, aluminum, nickel, vanadium, titanium, chromium, cobalt, gold, and tungsten. Copper and aluminum are more preferred, and copper is further preferred.
[0680] The method for forming the metal layer is not particularly limited, and existing methods can be applied. For example, the methods described in Japanese Patent Publication No. 2007-157879, Japanese Patent Table No. 2001-521288, Japanese Patent Publication No. 2004-214501, and Japanese Patent Publication No. 2004-101850 can be applied. For example, photolithography, lift-off, electrolytic plating, electroless plating, etching, printing, and methods combining these can be considered. More specifically, a patterning method combining sputtering, photolithography, and etching, and a patterning method combining photolithography and electrolytic plating can be cited.
[0681] The thickness of the metal layer is preferably 0.1 to 50 μm, more preferably 1 to 10 μm, at the thickest portion.
[0682] <Lamination process>
[0683] The production method of the present invention preferably further includes a lamination step.
[0684] The lamination step refers to a series of steps including performing (a) a film forming step (layer forming step), (b) an exposure step, (c) a developing step, and (d) a heating step again in order on the surface of the cured film (resin layer) or the metal layer. However, a method in which only the film forming step (a) is repeated may be adopted.
[0685] Furthermore, the heating step (d) may be performed at the end or in the middle of the stacking. That is, the steps (a) to (c) may be repeated a specified number of times, and then the heating step (d) may be performed, thereby curing the stacked curable resin composition layers at the same time. Furthermore, the metal layer forming step (e) may be included after the developing step (c), and in this case, the heating step (d) may be performed each time, or the heating step (d) may be performed at the same time after the stacking step is performed a specified number of times. Of course, the above-mentioned drying step or heating step may also be appropriately included in the stacking step.
[0686] When the lamination step is further performed after the lamination step, a surface activation treatment step may be further performed after the heating step, after the exposure step, or after the metal layer forming step. As the surface activation treatment, plasma treatment can be exemplified.
[0687] The lamination step is preferably performed 2 to 5 times, more preferably 3 to 5 times.
[0688] For example, the resin layer structure such as resin layer / metal layer / resin layer / metal layer / resin layer / metal layer is preferably 3 or more layers and 7 or less layers, and more preferably 3 or more layers and 5 or less layers.
[0689] In the present invention, it is particularly preferred that after the metal layer is provided, a cured film (resin layer) of the curable resin composition is further formed in a manner covering the metal layer. Specifically, a method of repeatedly performing the steps of (a) film forming step, (b) exposure step, (c) developing step, (e) metal layer forming step, and (d) heating step can be cited, or a method of repeatedly performing the steps of (a) film forming step, (b) exposure step, (c) developing step, and (e) metal layer forming step and providing (d) heating step at the end or in the middle can be cited. By alternately performing the stacking step of stacking the curable resin composition layer (resin layer) and the metal layer forming step, the curable resin composition layer (resin layer) and the metal layer can be alternately stacked.
[0690] The present invention also discloses a semiconductor device comprising the cured film or laminate of the present invention. As a specific example of a semiconductor device using the curable resin composition of the present invention for forming an interlayer insulating film for a redistribution layer, reference can be made to paragraphs 0213 to 0218 of Japanese Patent Application Publication No. 2016-027357 and the description of FIG. 1, which are incorporated into this specification.
[0691] Example
[0692] Below, give embodiment and the present invention is further specifically described.The material, usage amount, ratio, processing content, processing step etc. shown in the following embodiment can be appropriately changed as long as it does not depart from the purpose of the present invention.Therefore, the scope of the present invention is not limited to the specific example shown below.As long as there is no special description, "part", "%" are mass references.
[0693] <Synthesis example 1>
[0694] [A-1: Polyimide precursor resin A-1 synthesized from oxydiphthalic anhydride, 4,4'-diphthalic anhydride, 2-hydroxyethyl methacrylate and 4,4'-diaminodiphenyl ether]
[0695] In a dry reactor equipped with a stirrer, a condenser, and a flat-bottomed joint equipped with an internal thermometer, 9.49 g (32.25 mmol) of 4,4'-diphthalic anhydride and 10.0 g (32.25 mmol) of oxydiphthalic anhydride were suspended in 140 mL of diethylene glycol dimethyl ether while removing water. Subsequently, 16.8 g (129 mmol) of 2-hydroxyethyl methacrylate, 0.05 g of hydroquinone, 0.05 g of pure water, and 10.7 g (135 mmol) of pyridine were added, and stirred at 60°C for 18 hours. Then, after the mixture was cooled to -20°C, 16.1 g (135.5 mmol) of thionyl chloride was added dropwise over 90 minutes. A white precipitate of pyridinium hydrochloride was obtained. Next, the mixture was heated to room temperature, stirred for 2 hours, and then 9.7 g (123 mmol) of pyridine and 25 mL of N-methylpyrrolidone (NMP) were added to obtain a transparent solution. Next, a solution of 11.8 g (58.7 mmol) of 4,4'-diaminodiphenyl ether dissolved in 100 mL of NMP was added dropwise over 1 hour to the obtained transparent liquid. Next, 5.6 g (17.5 mmol) of methanol and 0.05 g of 3,5-di-tert-butyl-4-hydroxytoluene were added, and the mixture was stirred for 2 hours. Next, the polyimide precursor resin was precipitated in 4 liters of water, and the water-polyimide precursor resin mixture was stirred at a speed of 500 rpm for 15 minutes. The polyimide precursor resin was filtered to obtain the polyimide precursor resin, stirred again in 4 liters of water for 30 minutes, and filtered again. Next, the obtained polyimide precursor resin was dried at 45 ° C for 3 days under reduced pressure. The obtained polyimide precursor A-1 had a weight average molecular weight of 24,800 and a number average molecular weight of 10,500.
[0696] Furthermore, the acid value of the obtained polyimide precursor A-1 was 11.5 mgKOH / g.
[0697] <Synthesis example 2>
[0698] [A-2: Polyimide precursor resin A-2 synthesized from oxydiphthalic anhydride, 2-hydroxyethyl methacrylate and 4,4'-diaminodiphenyl ether]
[0699] In a dry reactor equipped with a stirrer, a condenser and a flat-bottomed joint equipped with an internal thermometer, 20.0 g (64.5 mmol) of oxydiphthalic dianhydride was suspended in 140 mL of diethylene glycol dimethyl ether while removing water. Subsequently, 16.8 g (129 mmol) of 2-hydroxyethyl methacrylate, 0.05 g of hydroquinone, 0.08 g of pure water and 10.7 g (135 mmol) of pyridine were added, and stirred at 60°C for 18 hours. Then, after the mixture was cooled to -20°C, 16.1 g (135.5 mmol) of thionyl chloride was added dropwise over 90 minutes. A white precipitate of pyridinium hydrochloride was obtained. Then, the mixture was heated to room temperature, stirred for 2 hours, and 9.7 g (123 mmol) of pyridine and 25 mL of N-methylpyrrolidone (NMP) were added to obtain a transparent solution. Then, a solution of 11.8 g (58.7 mmol) of 4,4'-diaminodiphenyl ether dissolved in 100 mL of NMP was added to the obtained transparent liquid by dropwise addition over 1 hour. Then, 5.6 g (17.5 mmol) of methanol and 0.05 g of 3,5-di-tert-butyl-4-hydroxytoluene were added, and the mixture was stirred for 2 hours. Then, the polyimide precursor resin was precipitated in 4 liters of water, and the water-polyimide precursor resin mixture was stirred at a speed of 500 rpm for 15 minutes. The polyimide precursor resin was filtered, stirred again in 4 liters of water for 30 minutes, and filtered again. Then, the obtained polyimide precursor resin was dried at 45 ° C for 3 days under reduced pressure. The weight average molecular weight of the obtained polyimide precursor A-2 was 23,500, and the number average molecular weight was 8,800.
[0700] Furthermore, the acid value of the obtained polyimide precursor A-2 was 15.8 mgKOH / g.
[0701] <Synthesis example 3>
[0702] [A-3: Synthesis of polybenzoxazole precursor A-3 from 2,2'-bis(3-amino-4-hydroxyphenyl)hexafluoropropane and 4,4'-oxydibenzoyl chloride]
[0703] 28.0 g (76.4 mmol) of 2,2'-bis(3-amino-4-hydroxyphenyl)hexafluoropropane was dissolved by stirring in 200 g of N-methylpyrrolidone. Subsequently, 12.1 g (153 mmol) of pyridine was added, and a solution of 20.7 g (70.1 mmol) of 4,4'-oxydibenzoyl chloride dissolved in 75 g of N-methylpyrrolidone was added dropwise over 1 hour while maintaining the temperature at -10 to 0°C. After stirring for 30 minutes, 1.00 g (12.7 mmol) of acetyl chloride was added and stirred for a further 60 minutes. Next, the polybenzoxazole precursor resin was precipitated in 6 liters of water, and the water-polybenzoxazole precursor resin mixture was stirred at 500 rpm for 15 minutes. The polybenzoxazole precursor resin was obtained by filtration, stirred again in 6 liters of water for 30 minutes, and filtered again. Next, the obtained polybenzoxazole precursor resin was dried under reduced pressure at 45° C. for 3 days. The obtained polybenzoxazole precursor A-3 had a weight average molecular weight of 21,500 and a number average molecular weight of 9,500.
[0704] The acid value of the obtained polybenzoxazole precursor A-3 was 190 mgKOH / g.
[0705] [Chemical formula 51]
[0706]
[0707] <Synthesis Example 4>
[0708] [Synthesis of a polyimide precursor from 4,4'-oxydiphthalic dianhydride, 4,4'-diaminodiphenyl ether and 2-hydroxyethyl methacrylate (A-4: a polyimide precursor having a radical polymerizable group)]
[0709] 155.1 g of 4,4'-oxydiphthalic anhydride (ODPA) was placed in a separable flask, and 134.0 g of 2-hydroxyethyl methacrylate (HEMA) and 400 ml of γ-butyrolactone were added. While stirring at room temperature, 79.1 g of pyridine was added to obtain a reaction mixture. After the heat generated by the reaction ended, the mixture was naturally cooled to room temperature and allowed to stand for 16 hours.
[0710] Next, under ice cooling, a solution of 206.3 g of dicyclohexylcarbodiimide (DCC) dissolved in 180 ml of γ-butyrolactone was added to the reaction mixture over 40 minutes while stirring. Subsequently, a suspension of 93.0 g of 4,4'-diaminodiphenyl ether dissolved in 350 ml of γ-butyrolactone was added over 60 minutes while stirring. After further stirring at room temperature for 2 hours, 30 ml of ethanol was added and stirred for 1 hour. Then, 400 ml of γ-butyrolactone was added. The precipitate generated in the reaction mixture was removed by filtration to obtain a reaction solution.
[0711] The obtained reaction solution was added to 3 liters of ethanol to generate a precipitate consisting of a crude polymer. The generated crude polymer was filtered and dissolved in 1.5 liters of tetrahydrofuran to obtain a crude polymer solution. The obtained crude polymer solution was added dropwise to 28 liters of water to precipitate the polymer, and the obtained precipitate was filtered and then vacuum dried to obtain a powdered polymer A-4. The weight average molecular weight (Mw) of the polymer A-4 was measured and the result was 20,000.
[0712] <Synthesis Example 5>
[0713] [Synthesis of a polyimide precursor (A-5: a polyimide precursor having a radical polymerizable group) from 3,3',4,4'-biphenyltetracarboxylic dianhydride, 4,4'-diaminodiphenyl ether and 2-hydroxyethyl methacrylate]
[0714] Polymer A-5 was obtained by the same reaction as in Synthesis Example 4 except that 147.1 g of 3,3',4,4'-biphenyltetracarboxylic dianhydride was used instead of 155.1 g of 4,4'-oxydiphthalic dianhydride. The weight average molecular weight (Mw) of the polymer A-5 was measured and found to be 22,000.
[0715] <Examples and Comparative Examples>
[0716] In each example described as "When preparing solution" in the "Method of adding specific compound" column, each curable resin composition was obtained by mixing the components described in Table 1 or Table 2 below. In addition, in each comparative example, each comparative composition was obtained by mixing the components described in Table 2 below.
[0717] In each example described as "immediately before film formation" in the "Method of adding specific compound" column, the components described in Table 1 or Table 2 other than the specific compound were mixed to obtain a precursor composition. Then, just before forming the curable resin composition layer in each evaluation, the specific compound described in Table 1 or Table 2 was mixed with the above-mentioned precursor composition to obtain a curable resin composition.
[0718] Specifically, the contents of the components described in Table 1 are the amounts described in “parts by mass” in Table 1.
[0719] The obtained curable resin composition and comparative composition were filtered under pressure through a polytetrafluoroethylene filter having a pore width of 0.8 μm.
[0720] In Table 1, for example, "A-1 / A-2" and "16 / 16" indicate that 16 parts by mass of A-1 and 16 parts by mass of A-2 are contained.
[0721] In Table 1, "-" indicates that the composition does not contain the corresponding component.
[0722] [Table 1]
[0723]
[0724] [Table 2]
[0725]
[0726] The details of each component described in Table 1 are as follows.
[0727] [Polymer precursor containing heterocyclic ring]
[0728] ·A-1 to A-5: A-1 to A-5 synthesized above
[0729] 〔Specific compounds〕
[0730] BE-1: N,N-dimethylcyclohexylamine
[0731] BE-2: triethylamine
[0732] BE-3: 2-(Dimethylamino)ethyl methacrylate
[0733] BE-4: Dicyclohexylamine
[0734] BE-5: 4-Dimethylaminopyridine
[0735] BE-6: Diisopropylamine
[0736] BE-7: 1,3,4,6,7,8-hexahydro-1-methyl-2H-pyrimido[1,2-a]pyrimidine
[0737] BE-8: Imidazole
[0738] BE-9: 1,2-Benzopyrazole
[0739] BE-10: 5-Methylpyrazole-3-carboxylic acid methyl ester
[0740] BE-11: N-isopropylaniline
[0741] ·B-1: 3-aminopropyltriethoxysilane
[0742] Compound B-1 is a compound containing an alkoxysilyl group and is not a specific compound.
[0743] B-2: Diethylamine
[0744] Compound B-2 is a compound having a hydrogen atom and not having a structure having a branched structure or a cyclic structure, and is a compound that does not belong to the specific compounds.
[0745] 〔Photopolymerization initiator〕
[0746] OXE-01: IRGACURE OXE 01 (manufactured by BASF)
[0747] OXE-02: IRGACURE OXE 02 (manufactured by BASF)
[0748] 〔Solvent〕
[0749] DMSO: dimethyl sulfoxide
[0750] GBL: gamma-butyrolactone
[0751] ·Ethyl lactate
[0752] ·NMP: N-methylpyrrolidone
[0753] In Table 1, the description of DMSO / GBL means that DMSO and GBL were mixed at a ratio of DMSO:GBL=20:80 (mass ratio).
[0754] In Table 1, the description of NMP / ethyl lactate means that ethyl lactate and N-methylpyrrolidone are mixed at a ratio of ethyl lactate:N-methylpyrrolidone=20:80 (mass ratio).
[0755] 〔Polymerizable compounds〕
[0756] SR-209: SR-209 (manufactured by Sartomer Company, Inc.)
[0757] SR-231: SR-231 (manufactured by Sartomer Company, Inc.)
[0758] SR-239: SR-239 (manufactured by Sartomer Company, Inc.)
[0759] A-DPH: Dipentaerythritol hexaacrylate (manufactured by Shin-Nakamura Chemical Co., Ltd.)
[0760] 〔Onium salt or thermal base generator〕
[0761] F-1 or F-2: a compound having the following structure.
[0762] [Chemical formula 52]
[0763]
[0764] 〔Polymerization inhibitor〕
[0765] G-1: 1,4-Benzoquinone
[0766] ·G-2: 4-Methoxyphenol
[0767] G-3: 1,4-dihydroxybenzene
[0768] ·G-4: 2-nitroso-1-naphthol (manufactured by Tokyo Chemical Industry Co., Ltd.)
[0769] 〔Metal Adhesion Improver〕
[0770] ·H-1~H-4: The following compounds
[0771] Et represents ethyl.
[0772] [Chemical formula 53]
[0773]
[0774] 〔Migration inhibitor〕
[0775] ·I-1: 1H-Tetrazole
[0776] 〔additive〕
[0777] ·J-1: N-phenyldiethanolamine (manufactured by Tokyo Chemical Industry Co., Ltd.)
[0778] In any of the curable resin compositions in the examples, the content of water was 0.1% by mass or less relative to the total mass of the solvent.
[0779] The water content was measured using a Karl Fischer moisture analyzer (product name: "MKC-710M", manufactured by KYOTO ELECTRONICS MANUFACTURING CO., LTD., Karl Fischer coulometric titration type).
[0780] <Evaluation>
[0781] [Evaluation of film strength (elongation at break)]
[0782] In each embodiment and comparative example, a curable resin composition or a comparative composition was applied to a silicon wafer by spin coating to form a curable resin composition layer. The silicon wafer to which the obtained curable resin composition layer was applied was dried on a hot plate at 100°C for 5 minutes to obtain a curable resin composition layer with a uniform thickness of about 15 μm on the silicon wafer. A stepper (Nikon NSR 2005i9C) was used to apply 500 mJ / cm 2 The exposure energy was i-ray exposed. The curable resin composition layer (resin layer) after the above exposure was heated at a heating rate of 10°C / min in a nitrogen atmosphere, and after reaching the temperature recorded in the curing temperature (°C) column of Table 1, it was heated for 3 hours. The cured resin layer (cured film) was immersed in a 4.9% by mass hydrofluoric acid aqueous solution, and the cured film was peeled off from the silicon wafer. The peeled cured film was punched using a puncher to produce a test piece with a sample width of 3mm and a sample length of 30mm. Using a tensile testing machine (Tensilon), the obtained test piece was measured at a crosshead rate of 300mm / min in the longitudinal direction of the film according to JIS-K6251 under an environment of 25°C and 65%RH (relative humidity). The evaluation was carried out 5 times each, and the arithmetic mean value of the elongation (elongation at break) when the film broke was used as an index value.
[0783] The index values were evaluated according to the following evaluation criteria, and the evaluation results are described in the "Film Strength" column of Table 1. It can be said that the larger the index value is, the better the film strength (elongation at break) of the obtained cured film is.
[0784] -Evaluation Criteria-
[0785] A: The above index value is 60% or more.
[0786] B: The above index value is 55% or more and less than 60%.
[0787] C: The above index value is 50% or more and less than 55%.
[0788] D: The above index value is less than 50%.
[0789] [Evaluation of storage stability (film change rate)]
[0790] -Measurement of film thickness before aging-
[0791] In each embodiment and comparative example, a curable resin composition or a comparative composition is applied to a silicon wafer by spin coating to form a curable resin composition layer. The silicon wafer to which the obtained curable resin composition layer is applied is dried on a hot plate for 5 minutes at 100°C, and a curable resin composition layer of uniform thickness of about 15 μm is obtained on the silicon wafer. The film thickness of the curable resin composition layer on the above-mentioned silicon wafer is measured, and its value is used as the film thickness before time. Regarding the film thickness, the film thickness measurement is implemented at 10 points on the coating surface using an ellipsometer (KT-22 manufactured by Foothill Company), and the film thickness is obtained as its arithmetic mean.
[0792] -Measurement of film thickness after time-
[0793] In each embodiment and comparative example, a curable resin composition or a comparative composition (a precursor composition in the embodiment described as "just before film formation" in the "addition method of a specific compound" column) is placed in a glass container and sealed, and after standing for 14 days at 25°C and in a light-shielded environment, a curable resin composition or a comparative composition (in the embodiment described as "just before film formation" in the "addition method of a specific compound" column, a specific compound is mixed in the precursor composition just before film formation) is applied to a silicon wafer by spin coating and using the same rotation speed as when the film thickness before time is obtained to form a curable resin composition layer. The silicon wafer to which the obtained curable resin composition layer is applied is dried on a hot plate for 5 minutes at 100°C, and a curable resin composition layer of uniform thickness is obtained on the silicon wafer. The film thickness of the obtained curable resin composition layer is measured by the same method as the film thickness measurement method in the above-mentioned film thickness measurement method before time, and its value is used as the film thickness after time.
[0794] -Film thickness change rate-
[0795] The film thickness change rate was calculated by the following formula.
[0796] Film thickness change rate (%) = |film thickness before time - film thickness after time| / film thickness before time × 100
[0797] The calculated film thickness change rate was evaluated according to the following evaluation criteria, and the evaluation results are described in the "Storage Stability" column of Table 1. It can be said that the smaller the film thickness change rate is, the better the storage stability of the curable resin composition is.
[0798] -Evaluation Criteria-
[0799] A: The above-mentioned film thickness change rate is less than 10%.
[0800] B: The film thickness change rate is 10% or more and less than 15%.
[0801] C: The film thickness change rate is 15% or more and less than 20%.
[0802] D: The film thickness change rate is 20% or more.
[0803] [Evaluation of chemical resistance (film change rate)]
[0804] In each embodiment and comparative example, a curable resin composition or a comparative composition was applied to a silicon wafer by spin coating to form a curable resin composition layer. The silicon wafer to which the obtained curable resin composition layer was applied was dried on a hot plate at 100° C. for 5 minutes to form a curable resin composition layer with a uniform thickness of 15 μm on the silicon wafer. The curable resin composition layer on the silicon wafer was irradiated with a stepper (Nikon NSR 2005 i9C) at 500 mJ / cm 2 The i-ray exposure was performed with an exposure energy of , and the exposed curable resin composition layer (resin layer) was heated at a heating rate of 10°C / min in a nitrogen atmosphere and heated at the temperature described in Table 1 for 3 hours to obtain a cured layer (resin layer) of the curable resin composition layer.
[0805] The obtained resin layer was immersed in the following chemical solution under the following conditions, and the dissolution rate was estimated.
[0806] Chemical solution: a mixture of dimethyl sulfoxide (DMSO) and a 25% by mass aqueous solution of tetramethylammonium hydroxide (TMAH) at a ratio of 90:10 (mass ratio)
[0807] Evaluation conditions: The resin layer was immersed in the above-mentioned chemical solution at 75°C for 15 minutes, the film thickness before and after immersion was compared, and the dissolution rate (nm / min) was calculated. The film thickness was measured at 10 points on the coated surface using an ellipsometer (KT-22 manufactured by Foothill Corporation), and the film thickness was calculated as the arithmetic mean.
[0808] Evaluation was performed according to the following evaluation criteria, and the evaluation results are described in the "Chemical Resistance" column of Table 1. It can be said that the smaller the value of the dissolution rate is, the more excellent the chemical resistance of the obtained cured film (resin layer) is.
[0809] -Evaluation Criteria-
[0810] A: The dissolution rate is less than 200 nm / min.
[0811] B: The dissolution rate is 200 nm / min or more and less than 300 nm / min.
[0812] C: The dissolution rate is 300 nm / min or more and less than 400 nm / min.
[0813] D: The dissolution rate is 400 nm / min or more.
[0814] From the above results, it is understood that the cured film of the curable resin composition of the present invention comprising a polymer precursor containing a heterocyclic ring, a specific compound, a polymerization initiator, and a solvent is excellent in film strength.
[0815] The curable resin compositions of Comparative Examples 1 to 6 do not contain a specific compound. It is found that the cured films of the curable resin compositions of Comparative Examples 1 to 6 have poor film strength.
[0816] <Example 101>
[0817] By spin coating, the curable resin composition used in Example 1 was applied in layers to the surface of the copper thin layer of the resin substrate having a copper thin layer formed on the surface, and dried at 100°C for 5 minutes to form a curable resin composition layer with a film thickness of 20 μm, and then exposed using a stepper (Nikon Co., Ltd., NSR1505 i6). Exposure was performed at a wavelength of 365 nm through a mask (a binary mask with a pattern of 1:1 lines and spaces and a line width of 10 μm). After exposure, the pattern of the layer was obtained by developing with cyclopentanone for 30 seconds and rinsing with PGMEA for 20 seconds.
[0818] Next, heating was performed at 230° C. for 3 hours to form an interlayer insulating film for a rewiring layer. The interlayer insulating film for a rewiring layer had excellent insulating properties.
[0819] Furthermore, semiconductor devices were manufactured using these interlayer insulating films for redistribution wiring layers, and it was confirmed that the devices operated without any problems.
Claims
1. A curable resin composition comprising: At least one resin selected from the group consisting of a polyimide precursor and a polybenzoxazole precursor; A basic compound represented by the following formula (1-1); a polymerization initiator; and Solvents, The basic compound is at least one basic compound selected from the group consisting of aromatic secondary amines and nitrogen-containing heterocyclic compounds, The nitrogen-containing heterocyclic compound is a substituted pyrazole compound, a substituted or unsubstituted benzopyrazole compound, or 1,3,4,6,7,8-hexahydro-1-methyl-2H-pyrimido[1,2-a]pyrimidine, The molecular weight of the basic compound is 60 to 200, In formula (1-1), R 1 ~R 3 Each independently represents a hydrogen atom, a substituted or unsubstituted alkyl group, or a substituted or unsubstituted aromatic group, wherein R 1 ~R 3 The substituent of the alkyl group in is selected from an aromatic hydrocarbon group, an aromatic heterocyclic group, an alkoxy group, an alkoxycarbonyl group, an aryloxycarbonyl group, a vinyl group, an allyl group, a (meth)acrylamide group, a methacryloxy group, and R 1 ~R 3 At least two of them are optionally bonded to form a ring structure, R 1 ~R 3 does not contain an alkoxysilyl group as a substituent, when R 1 ~R 3 When at least one of them is a hydrogen atom, R 1 ~R 3 At least one of the other ones of represents a structure having a branched structure or a cyclic structure.
2. The curable resin composition according to claim 1, wherein The basic compound is a monoamine compound.
3. The curable resin composition according to claim 1 or 2, wherein The content of the basic compound is 0.2% by mass to 10% by mass based on the total solid content of the composition.
4. The curable resin composition according to claim 1 or 2, wherein The resin is a polyimide precursor having a repeating unit represented by the following formula (1): In formula (1), A 1 and A 2 Each independently represents an oxygen atom or NH, R 111 represents a divalent organic group, R 115 represents a tetravalent organic group, R 113 and R 114 Each independently represents a hydrogen atom or a monovalent organic group.
5. The curable resin composition according to claim 4, wherein The R 113 and R 114 At least one of the compounds comprises a free radical polymerizable group.
6. The curable resin composition according to claim 1 or 2, wherein The acid value of the resin is 8 mgKOH / g to 80 mgKOH / g.
7. The curable resin composition according to claim 1 or 2, wherein The content of water is 5% by mass or less relative to the total mass of the solvent. 8 . The curable resin composition according to claim 1 , further comprising a radical polymerizable compound. 9 . The curable resin composition according to claim 1 , further comprising at least one selected from the group consisting of an onium salt and a thermal base generator. 10 . The curable resin composition according to claim 1 , which is used for forming an interlayer insulating film for a rewiring layer.
11. A method for producing a curable resin composition, which is a method for producing the curable resin composition according to any one of claims 1 to 10, the method comprising the following steps: A composition including the resin, the polymerization initiator, and the solvent and a basic compound represented by formula (1-1) are mixed. 12 . A cured film formed by curing the curable resin composition according to claim 1 . 13 . A laminate comprising two or more layers of the cured film according to claim 12 , wherein a metal layer is provided between any of the cured films.
14. A method for producing a cured film, comprising: The film forming step is to apply the curable resin composition according to any one of claims 1 to 10 to a substrate to form a film. 15 . The method for producing a cured film according to claim 14 , comprising, before the film forming step, a step of mixing a composition containing the resin, the polymerization initiator and the solvent and a basic compound having a structure represented by formula (1-1) to produce the curable resin composition.
16. The method for producing a cured film according to claim 14, comprising: An exposure step of exposing the film to light; and a developing step for developing the film.
17. The method for producing a cured film according to claim 14, comprising: In the heating step, the film is heated at 50°C to 450°C. 18 . A semiconductor device comprising the cured film according to claim 12 .
